<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JNCI Cancer Spectr</journal-id><journal-id journal-id-type="iso-abbrev">JNCI Cancer Spectr</journal-id><journal-id journal-id-type="pmc-domain-id">3695</journal-id><journal-id journal-id-type="pmc-domain">jncicanspec</journal-id><journal-id journal-id-type="publisher-id">jncics</journal-id><journal-title-group><journal-title>JNCI Cancer Spectrum</journal-title></journal-title-group><issn pub-type="epub">2515-5091</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11149920</article-id><article-id pub-id-type="pmcid-ver">PMC11149920.1</article-id><article-id pub-id-type="pmcaid">11149920</article-id><article-id pub-id-type="pmcaiid">11149920</article-id><article-id pub-id-type="pmid">38702757</article-id><article-id pub-id-type="doi">10.1093/jncics/pkae031</article-id><article-id pub-id-type="publisher-id">pkae031</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Meta-Analysis</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00010</subject></subj-group></article-categories><title-group><article-title>A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7695-675X</contrib-id><name name-style="western"><surname>Jimenez-Labaig</surname><given-names initials="P">Pablo</given-names></name><degrees>MD</degrees><aff>
<institution>Head and Neck Unit, The Royal Marsden NHS Foundation Trust</institution>, London, <country country="GB">UK</country></aff><aff>
<institution>The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre</institution>, London, <country country="GB">UK</country></aff><xref rid="pkae031-FM1" ref-type="author-notes"/><xref rid="pkae031-cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0040-1608</contrib-id><name name-style="western"><surname>Aymerich</surname><given-names initials="C">Claudia</given-names></name><degrees>MD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft">Writing - original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing">Writing - review &amp; editing</role><aff>
<institution>Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Biobizkaia Health Research Institute, OSI Bilbao-Basurto</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Centro de Investigaci&#243;n en Red de Salud Mental (CIBERSAM)</institution>, Madrid, <country country="ES">Spain</country></aff><xref rid="pkae031-FM1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1068-9601</contrib-id><name name-style="western"><surname>Bra&#241;a</surname><given-names initials="I">Irene</given-names></name><degrees>MD, PhD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing">Writing - review &amp; editing</role><aff>
<institution>Lung and Head &amp; Neck Tumors Unit. Medical Oncology Department, Vall d&#8216;Hebron University Hospital</institution>, Barcelona, <country country="ES">Spain</country></aff><aff>
<institution>Vall d&#8217;Hebron Institute of Oncology (VHIO)</institution>, Barcelona, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7365-9629</contrib-id><name name-style="western"><surname>Rullan</surname><given-names initials="A">Antonio</given-names></name><degrees>MD, PhD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing">Writing - review &amp; editing</role><aff>
<institution>Head and Neck Unit, The Royal Marsden NHS Foundation Trust</institution>, London, <country country="GB">UK</country></aff><aff>
<institution>The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre</institution>, London, <country country="GB">UK</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6195-8034</contrib-id><name name-style="western"><surname>Cacicedo</surname><given-names initials="J">Jon</given-names></name><degrees>MD, PhD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><aff>
<institution>Radiotherapy Department, Cruces University Hospital</institution>, Barakaldo, <country country="ES">Spain</country></aff><aff>
<institution>Biobizkaia Health Research Institute, OSI Ezkerraldea Enkarterri Cruces</institution>, Barakaldo, <country country="ES">Spain</country></aff><aff>
<institution>Faculty of Medicine, University of the Basque Country</institution>, Leioa, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4017-2785</contrib-id><name name-style="western"><surname>Gonz&#225;lez-Torres</surname><given-names initials="M&#xC1;">Miguel &#193;ngel</given-names></name><degrees>MD, PhD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision">Supervision</role><aff>
<institution>Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Biobizkaia Health Research Institute, OSI Bilbao-Basurto</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Centro de Investigaci&#243;n en Red de Salud Mental (CIBERSAM)</institution>, Madrid, <country country="ES">Spain</country></aff><aff>
<institution>Neuroscience Department, University of the Basque Country (UPV/EHU)</institution>, Leioa, <country country="ES">Spain</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6014-348X</contrib-id><name name-style="western"><surname>Harrington</surname><given-names initials="KJ">Kevin J</given-names></name><degrees>MD, PhD, MBBS</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision">Supervision</role><aff>
<institution>Head and Neck Unit, The Royal Marsden NHS Foundation Trust</institution>, London, <country country="GB">UK</country></aff><aff>
<institution>The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre</institution>, London, <country country="GB">UK</country></aff><xref rid="pkae031-FM2" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Catalan</surname><given-names initials="A">Ana</given-names></name><degrees>MD, PhD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision">Supervision</role><aff>
<institution>Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Biobizkaia Health Research Institute, OSI Bilbao-Basurto</institution>, Bilbao, <country country="ES">Spain</country></aff><aff>
<institution>Centro de Investigaci&#243;n en Red de Salud Mental (CIBERSAM)</institution>, Madrid, <country country="ES">Spain</country></aff><aff>
<institution>Neuroscience Department, University of the Basque Country (UPV/EHU)</institution>, Leioa, <country country="ES">Spain</country></aff><aff>
<institution>Department of Psychiatry, University of Oxford</institution>, Oxford, <country country="GB">UK</country></aff><xref rid="pkae031-FM2" ref-type="author-notes"/></contrib></contrib-group><author-notes><corresp id="pkae031-cor1"><bold>Correspondence to:</bold> Pablo Jimenez-Labaig, MD, Head and Neck Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Rd, London SW3 6JJ, UK (e-mail: <email>pablo.jimenez@rmh.nhs.uk</email>).</corresp><fn id="pkae031-FM1"><p>Pablo Jimenez-Labaig and Claudia Aymerich contributed equally to this work and share first authorship.</p></fn><fn id="pkae031-FM2"><p>Kevin J Harrington and Ana Catalan contributed equally to this work and share senior authorship.</p></fn></author-notes><pub-date pub-type="collection"><month>6</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-05-03"><day>03</day><month>5</month><year>2024</year></pub-date><volume>8</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">461393</issue-id><elocation-id>pkae031</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2024</year></date><date date-type="rev-recd"><day>4</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2024</year></date><date date-type="corrected-typeset"><day>04</day><month>6</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>04</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-05 17:25:12.627"><day>05</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024. Published by Oxford University Press.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pkae031.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pkae031.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>Patients with head and neck cancer present particularly considerable levels of emotional distress. However, the actual rates of clinically relevant mental health symptoms and disorders among this population remain unknown.</p></sec><sec id="s2"><title>Methods</title><p>A Preferred Reporting Items for Systematic Review and Meta-Analyses and Meta-analyses of Observational Studies in Epidemiology&#8211;compliant systematic review and quantitative random-effects meta-analysis was performed to determine suicide incidence and the prevalence of depression, anxiety, distress, posttraumatic stress, and insomnia in this population. MEDLINE, Web of Science, Cochrane Central Register, KCI Korean Journal database, SciELO, Russian Science Citation Index, and Ovid-PsycINFO databases were searched from database inception to August 1, 2023 (PROSPERO: CRD42023441432). Subgroup analyses and meta-regressions were performed to investigate the effect of clinical, therapeutical, and methodological factors.</p></sec><sec id="s3"><title>Results</title><p>A total of 208 studies (n&#8201;=&#8201;654&#8202;413; median age = 60.7 years; 25.5% women) were identified. Among the patients, 19.5% reported depressive symptoms (95% confidence interval [CI] = 17% to 21%), 17.8% anxiety symptoms (95% CI&#8201;=&#8201;14% to 21%), 34.3% distress (95% CI&#8201;=&#8201;29% to 39%), 17.7% posttraumatic symptoms (95% CI&#8201;=&#8201;6% to 41%), and 43.8% insomnia symptoms (95% CI&#8201;=&#8201;35% to 52%). Diagnostic criteria assessments revealed lower prevalence of disorders: 10.3% depression (95% CI&#8201;=&#8201;7% to 13%), 5.6% anxiety (95% CI&#8201;=&#8201;2% to 10%), 9.6% insomnia (95% CI&#8201;=&#8201;1% to 40%), and 1% posttraumatic stress (95% CI&#8201;=&#8201;0% to 84.5%). Suicide pooled incidence was 161.16 per 100&#8202;000 individuals per year (95% CI&#8201;=&#8201;82 to 239). Meta-regressions found a statistically significant higher prevalence of anxiety in patients undergoing primary chemoradiation compared with surgery and increased distress in smokers and advanced tumor staging. European samples exhibited lower prevalence of distress.</p></sec><sec id="s4"><title>Conclusions</title><p>Patients with head and neck cancer presented notable prevalence of mental health concerns in all domains. Suicide remains a highly relevant concern. The prevalence of criteria-meeting disorders is significantly lower than clinically relevant symptoms. Investigating the effectiveness of targeted assessments for disorders in highly symptomatic patients is essential.</p></sec></abstract><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Tumors of the head and neck region represent a diverse group of cancers including oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, and salivary gland cancer. These malignancies are a meaningful global health concern across countries of varying levels of development. In 2020, head and neck cancer represented the seventh most common cancer globally, as reported by the Global Cancer Observatory (<xref rid="pkae031-B1" ref-type="bibr">1</xref>). Projections for 2030 suggest an alarming global increase, mainly led by those tumors related to human papillomavirus (<xref rid="pkae031-B2" ref-type="bibr">2</xref>).</p><p>Head and neck cancer is associated with particularly relevant levels of emotional distress (<xref rid="pkae031-B3" ref-type="bibr">3</xref>,<xref rid="pkae031-B4" ref-type="bibr">4</xref>). This can be attributed to several factors. This type of cancer is associated with high rates of comorbidity with medical, psychological, and substance abuse disorders (<xref rid="pkae031-B5" ref-type="bibr">5</xref>). Moreover, the impact of the tumor, together with surgical, radiotherapeutic, and systemic treatments, often in combination, can result in a range of functional impairments (<xref rid="pkae031-B6" ref-type="bibr">6</xref>). These encompass difficulties in speech, swallowing, loss of smell and taste, hearing, and even dyspnea (<xref rid="pkae031-B6" ref-type="bibr">6</xref>,<xref rid="pkae031-B7" ref-type="bibr">7</xref>). Additionally, the possibility of physical disfigurement adds a substantial psychological burden (<xref rid="pkae031-B8" ref-type="bibr">8</xref>) and further compromises the quality of life of the affected patients (<xref rid="pkae031-B9" ref-type="bibr">9</xref>).</p><p>Indeed, Hammermuller et al. (<xref rid="pkae031-B10" ref-type="bibr">10</xref>) reported high symptomatic scores for depression, anxiety, and fatigue in this population, along with a lower overall quality of life. Wu and colleagues (<xref rid="pkae031-B11" ref-type="bibr">11</xref>) also reported a prevalence of anxiety and depression of more than 25% after a head and neck cancer diagnosis. Suicide is not an exception: Cancer patients are at double the risk of suicide compared with the general population, whereas individuals with head and neck malignancies are 3 times more likely to commit suicide (<xref rid="pkae031-B12" ref-type="bibr">12</xref>).</p><p>However, identifying emotional distress in this population remains a considerable challenge. The disease can manifest symptoms such as fatigue, loss of appetite, and sleep disturbances (<xref rid="pkae031-B13" ref-type="bibr">13</xref>,<xref rid="pkae031-B14" ref-type="bibr">14</xref>), effectively masking potential underlying psychiatric conditions. Moreover, clinicians often lack sufficient time for a detailed assessment of this aspect of the illness, coupled with the limited diagnostic skills of many health-care professionals in recognizing such symptoms (<xref rid="pkae031-B15" ref-type="bibr">15</xref>,<xref rid="pkae031-B16" ref-type="bibr">16</xref>); all contribute to the complexity of the situation. To address these challenges, various self-report questionnaires are employed to detect symptoms associated with disorders such as depression (<xref rid="pkae031-B17" ref-type="bibr">17</xref>), anxiety (<xref rid="pkae031-B18" ref-type="bibr">18</xref>), distress (<xref rid="pkae031-B19" ref-type="bibr">19</xref>), insomnia (<xref rid="pkae031-B20" ref-type="bibr">20</xref>), and posttraumatic stress (<xref rid="pkae031-B21" ref-type="bibr">21</xref>). In other studies, structured interviews have been used to diagnose these conditions, following the criteria established in diagnostic manuals (<xref rid="pkae031-B22" ref-type="bibr">22</xref>,<xref rid="pkae031-B23" ref-type="bibr">23</xref>).</p><p>Although some prior systematic reviews have explored the prevalence of specific psychological symptoms in cancer patients, such as depression (<xref rid="pkae031-B24" ref-type="bibr">24</xref>) or distress (<xref rid="pkae031-B4" ref-type="bibr">4</xref>), to the best of our knowledge this is the first comprehensive systematic review or meta-analysis that thoroughly investigates all available clinical mental health domains and the factors that influence them in the distinct population of patients with head and neck cancer. Moreover, it is still unclear whether the symptomatic burden observed in this population, as assessed through self-reported scales, reaches the threshold for specific psychiatric disorders.</p><p>In this review, we systematically researched the literature to determine meta-analytically the prevalence of psychological symptoms and/or disorders (including depression, anxiety, distress, posttraumatic stress, insomnia, and committed suicide) among patients with head and neck cancer. Additionally, we sought to examine whether this prevalence is influenced by demographic and clinical factors (eg, age, sex, the location of the primary tumor, timing of assessment, type of treatment or comorbidities) or methodological aspects related to diagnosis, including the scale or diagnostic interview, publication year, or publication bias.</p><sec sec-type="methods"><title>Methods</title><p>This study protocol was registered on PROSPERO (registration number: CRD42023441432). The study was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (<xref rid="pkae031-B25" ref-type="bibr">25</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>, available online) and Meta-analyses of Observational Studies in Epidemiology checklist (<xref rid="pkae031-B26" ref-type="bibr">26</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 2</xref>, available online), following EQUATOR Reporting Guidelines (<xref rid="pkae031-B27" ref-type="bibr">27</xref>).</p><sec><title>Search strategy and selection criteria</title><p>A systematic literature search was carried out by 2 independent researchers (PJL and CA). Web of Science database (Clarivate Analytics) was searched, incorporating the Web of Science Core Collection, the BIOSIS Citation Index, the KCI Korean Journal Database, MEDLINE, the Russian Science Citation Index, and the SciELO Citation Index as well as Cochrane Central Register of Reviews, and Ovid PsycINFO databases, from inception until August 1, 2023.</p><p>The following keywords were used: (&#8220;cancer*&#8221; OR &#8220;neoplasm*&#8221; OR &#8220;tumour*&#8221; OR &#8220;tumor*&#8221; OR &#8220;malignan*&#8221;) AND (&#8220;head and neck&#8221; OR &#8220;head &amp; neck&#8221; OR &#8220;larynx&#8221; OR &#8220;*pharynx&#8221; OR &#8220;oral cavity&#8221; OR &#8220;sinus&#8221; OR &#8220;cavum&#8221; OR &#8220;salivary&#8221; OR &#8220;nasal cavity&#8221; OR &#8220;tongue&#8221; OR &#8220;tonsil*&#8221;) AND (&#8220;suicide*&#8221; OR &#8220;depress*&#8221; OR &#8220;anxiety&#8221; OR &#8220;anxious&#8221; OR &#8220;insomnia*&#8221; OR &#8220;post-traumatic&#8221; OR &#8220;PTSD&#8221; OR &#8220;stress&#8221; OR &#8220;distress*&#8221;).</p><p>Articles identified were first screened as abstracts, and after the exclusion of those that did not meet the inclusion criteria, the full texts of the remaining articles were assessed for eligibility and inclusion. The search was completed by manually searching through references of previously published systematic reviews and meta-analyses on the topic.</p><p>Inclusion criteria for the systematic review and meta-analysis were 1) individual studies with original data; 2) focusing on samples containing more than 90% of patients with a histological diagnosis of a head and neck cancer (including oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity, and salivary glands); 3) reporting prevalence about mental health outcomes included in at least 1 of the following categories: anxiety, depression, acute stress or distress, posttraumatic symptoms, sleep disturbances, and suicide; 4) using validated, structured, evaluation scales; 5) nonoverlapping samples (overlap was determined by looking at the inclusion dates and country in which the study was carried out; in case of overlapping, the study with the largest sample was selected); and 6) written in English or Spanish. Exclusion criteria were 1) reviews, clinical cases, study protocols or qualitative studies, conferential proceedings, letters, and commentaries; 2) reporting outcomes on populations with malignancies of different origins than those reported under the inclusion criteria; and 3) including samples already selected based on their psychological distress. Studies including interventions targeting emotional distress were not excluded if a control group with standard treatment was included, for which the data were extracted.</p></sec><sec><title>Data extraction</title><p>Two researchers (PJL and CA) independently extracted data from all the included studies. The 2 databases were then cross-checked, and discrepancies were resolved through consensus under the supervision of a senior researcher (AC). A summary of the selected variables included first author and year of publication, country and city, sample size, age (mean [SD]), sex (% female), primary tumor location, cancer stage, treatment intent, type of treatment, mental health domain studied, evaluation tool used, quality assessment (see below), and key findings. When multiple timepoints were available for a particular sample, the measurement immediately following treatment completion (or the closest to it, if the former was not available) was selected.</p></sec><sec><title>Risk of bias (quality) assessment</title><p>Risk of bias was assessed using a modified version of the Newcastle&#8211;Ottawa Scale for assessing the quality of nonrandomized studies because of the heterogeneity expected in the included studies. Studies were awarded 0-9 points according to their representativeness, exposure, outcomes, comparability, and follow-up period (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 3</xref>, available online). Scores of at least 7, 4-6, and less than 4 are considered low, intermediate, and high risk of bias, respectively (<xref rid="pkae031-B28" ref-type="bibr">28</xref>). Interrater agreement between the 2 reviewers was 0.87.</p></sec><sec><title>Strategy for data synthesis</title><p>First, we provided a systematic synthesis (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 4</xref>, available online) of the findings from the included studies structured around the selected 6 mental health outcomes: depression, anxiety, distress, posttraumatic symptoms, insomnia, and suicide. Second, we performed meta-analyses using, as primary effect size, the prevalence (% and standard error, when available) of mental health outcomes in people with head and neck cancer. For suicide, incidence rate and standard error for each included study was extracted (or calculated where data allowed for it) and then meta-analyzed. As heterogeneity was expected to be high, random-effects meta-analysis models were used for all the studied variables. Meta-regressions using group-level data were performed to determine the effect of age, sex, alcohol and tobacco use, education, employment status, race, civil status, primary tumor location, cancer stage, months since diagnosis, treatment, laryngectomy, pain, and dysphagia, when at least 7 studies provided data. Sensitivity analyses were conducted to estimate the association between the mental health domains and the assessment scale or interview, the continent where the study took place, and the time when the mental health domain was measured (categorized as pretreatment, during treatment, first year after treatment finalization, and more than 1 year after treatment finalization). Heterogeneity among studies was assessed using the <italic toggle="yes">Q</italic> statistic, with the proportion of the total variability in the effect size estimates evaluated using the <italic toggle="yes">I</italic><sup>2</sup> index (with an <italic toggle="yes">I</italic><sup>2</sup> &gt; 50% representing significant heterogeneity) (<xref rid="pkae031-B29" ref-type="bibr">29</xref>). Publication biases were assessed for the prevalence of symptomatic subjects for each mental health domain by inspecting funnel plots and assessing Egger test (<xref rid="pkae031-B30" ref-type="bibr">30</xref>).</p><p>All analyses were conducted using R 4.2.2 (<xref rid="pkae031-B31" ref-type="bibr">31</xref>). The significance level was set at as 2-sided and a <italic toggle="yes">P&#8201;</italic>value less than .05.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The literature search yielded 4838 citations through electronic database, which were screened for eligibility; 717 articles were assessed in full text, and 509 were excluded. No additional studies were included through manual search. The final database for the systematic review and meta-analysis included 208 studies (<xref rid="pkae031-F1" ref-type="fig">Figure&#160;1</xref>), encompassing 654&#8202;413 patients.</p><fig position="float" id="pkae031-F1" orientation="portrait"><label>Figure 1.</label><caption><p>Preferred Reporting Items for Systematic Reviews and Meta-Analysis 2020 flow diagram.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pkae031f1.jpg"/></fig><p>A total of 154 (74.0%) studies focused on depression (127 on depressive symptoms and 27 on depressive disorders), 95 (45.6%) on anxiety (80 on anxiety symptoms and 15 on anxiety disorders), 38 (18.3%) on distress, 9 (4.3%) on insomnia (including 3 on insomnia-related symptoms and 6 on sleep disorders), and 6 (2.9%) on posttraumatic symptoms (3 studies) or disorders (3 studies) (<xref rid="pkae031-F2" ref-type="fig">Figure&#160;2</xref>). Four additional articles included data on suicide and/or suicidality. The median age of the sample was 60.7&#8201;years, and 25.5% were female. Studies included data on patients with a histological diagnosis of primary malignancies of oral cavity (38.7%), oropharynx (27.5%), nasopharynx (7.5%), larynx and hypopharynx (23.4%), or other head and neck sites (2.9%). Of the patients, 36.6% had stage I or II tumors and 63.4% stage III or IV tumors. Of the patients, 21.5% underwent a therapeutical surgery, and 71.5% radiotherapy at some point; 40.3% received primary chemoradiotherapy and 23.2% neoadjuvant or adjuvant chemotherapy. Of the studies, 70% exclusively included patients treated with curative intent. Mean Newcastle&#8211;Ottawa scale of the included studies was 6.36 (0.98) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 4</xref>, available online). Heterogeneity was statistically significant for all the studied outcomes (<xref rid="pkae031-T1" ref-type="table">Table&#160;1</xref> and <xref rid="pkae031-T2" ref-type="table">Table&#160;2</xref>).</p><fig position="float" id="pkae031-F2" orientation="portrait"><label>Figure 2.</label><caption><p>Distribution of the prevalence of disturbances (%) of mental health domains among patients with head and neck cancer, according to clinically significant symptoms (<bold>black</bold>) and disorders (<bold>gray</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pkae031f2.jpg"/></fig><table-wrap position="float" id="pkae031-T1" orientation="portrait"><label>Table 1.</label><caption><p>Prevalence of mental health symptoms across each of the domains and scales studied<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Scale</th><th rowspan="2" colspan="1">No. studies</th><th rowspan="2" colspan="1">Sample size</th><th rowspan="2" colspan="1">Prevalence (95% CI)</th><th colspan="2" rowspan="1">Heterogeneity<hr/></th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">I</italic>
<sup>2</sup>, %</th><th rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> Depression</td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">23&#8202;302</td><td rowspan="1" colspan="1">0.195 (0.173 to 0.218)</td><td rowspan="1" colspan="1">93.3</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> HADS-D (<xref rid="pkae031-B32" ref-type="bibr">32</xref>)</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">10&#8202;698</td><td rowspan="1" colspan="1">0.168 (0.143 to 0.197)</td><td rowspan="1" colspan="1">89.4</td><td rowspan="1" colspan="1">.01</td></tr><tr><td rowspan="1" colspan="1"> CES-D (<xref rid="pkae031-B33" ref-type="bibr">33</xref>)</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2156</td><td rowspan="1" colspan="1">0.301 (0.237 to 0.375)</td><td rowspan="1" colspan="1">86.5</td><td rowspan="1" colspan="1">.01</td></tr><tr><td rowspan="1" colspan="1"> BDI (<xref rid="pkae031-B34" ref-type="bibr">34</xref>)</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1853</td><td rowspan="1" colspan="1">0.166 (0.123 to 0.222)</td><td rowspan="1" colspan="1">81.4</td><td rowspan="1" colspan="1">.02</td></tr><tr><td rowspan="1" colspan="1"> PHQ-9 (<xref rid="pkae031-B35" ref-type="bibr">35</xref>)</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">2639</td><td rowspan="1" colspan="1">0.139 (0.110 to 0.174)</td><td rowspan="1" colspan="1">81.0</td><td rowspan="1" colspan="1">.03</td></tr><tr><td rowspan="1" colspan="1"> GDS (<xref rid="pkae031-B36" ref-type="bibr">36</xref>)</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">3009</td><td rowspan="1" colspan="1">0.380 (0.242 to 0.541)</td><td rowspan="1" colspan="1">94.6</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> SDS (<xref rid="pkae031-B37" ref-type="bibr">37</xref>)</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">436</td><td rowspan="1" colspan="1">0.333 (0.012 to 0.955)</td><td rowspan="1" colspan="1">97.4</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> BSI-18 (<xref rid="pkae031-B38" ref-type="bibr">38</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">125</td><td rowspan="1" colspan="1">0.140 (0.089 to 0.213)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> QIDS-SR (<xref rid="pkae031-B39" ref-type="bibr">39</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">71</td><td rowspan="1" colspan="1">0.183 (0.109 to 0.290)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> ESAS-D (<xref rid="pkae031-B40" ref-type="bibr">40</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">161</td><td rowspan="1" colspan="1">0.270 (0.207 to 0.344)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> BDI-FS (<xref rid="pkae031-B41" ref-type="bibr">41</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1">0.190 (0.117 to 0.293)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> WHO-5 (<xref rid="pkae031-B42" ref-type="bibr">42</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">453</td><td rowspan="1" colspan="1">0.251 (0.213 to 0.293)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> MDI (<xref rid="pkae031-B43" ref-type="bibr">43</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">235</td><td rowspan="1" colspan="1">0.100 (0.068 to 0.145)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> DS (<xref rid="pkae031-B44" ref-type="bibr">44</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1234</td><td rowspan="1" colspan="1">0.088 (0.073 to 0.105)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> MAAC (<xref rid="pkae031-B45" ref-type="bibr">45</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">0.403 (0.282 to 0.536)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Mini-5 (<xref rid="pkae031-B46" ref-type="bibr">46</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">0.490 (0.394 to 0.587)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Anxiety</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">10&#8202;478</td><td rowspan="1" colspan="1">0.178 (0.145 to 0.215)</td><td rowspan="1" colspan="1">90.9</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> HADS-A (<xref rid="pkae031-B32" ref-type="bibr">32</xref>)</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">7466</td><td rowspan="1" colspan="1">0.162 (0.134 to 0.193)</td><td rowspan="1" colspan="1">88.0</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> GAD-7 (<xref rid="pkae031-B47" ref-type="bibr">47</xref>)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">825</td><td rowspan="1" colspan="1">0.082 (0.049 to 0.134)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> STAI (<xref rid="pkae031-B48" ref-type="bibr">48</xref>)</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1412</td><td rowspan="1" colspan="1">0.511 (0.114 to 0.894)</td><td rowspan="1" colspan="1">97.5</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> BAI (<xref rid="pkae031-B49" ref-type="bibr">49</xref>)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">258</td><td rowspan="1" colspan="1">0.181 (0.035 to 0.576)</td><td rowspan="1" colspan="1">89.2</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> SAS (<xref rid="pkae031-B50" ref-type="bibr">50</xref>)</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">315</td><td rowspan="1" colspan="1">0.596 (0.000 to 1.000)</td><td rowspan="1" colspan="1">98.5</td><td rowspan="1" colspan="1">&lt; .01</td></tr><tr><td rowspan="1" colspan="1"> ESAS-A (<xref rid="pkae031-B40" ref-type="bibr">40</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">161</td><td rowspan="1" colspan="1">0.230 (0.172 to 0.301)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> MAS (<xref rid="pkae031-B51" ref-type="bibr">51</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">0.412 (0.276 to 0.569)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Distress</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">5057</td><td rowspan="1" colspan="1">0.343 (0.298 to 0.390)</td><td rowspan="1" colspan="1">88.2</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> HADS-T (<xref rid="pkae031-B32" ref-type="bibr">32</xref>)</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2040</td><td rowspan="1" colspan="1">0.306 (0.249 to 0.370)</td><td rowspan="1" colspan="1">84.5</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> DT (<xref rid="pkae031-B52" ref-type="bibr">52</xref>)</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">2479</td><td rowspan="1" colspan="1">0.431 (0.372 to 0.492)</td><td rowspan="1" colspan="1">86.1</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1"> ASDS (<xref rid="pkae031-B53" ref-type="bibr">53</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">73</td><td rowspan="1" colspan="1">0.120 (0.063 to 0.216)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> GSI (<xref rid="pkae031-B54" ref-type="bibr">54</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">0.224 (0.129 to 0.361)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> GHQ-12 (<xref rid="pkae031-B55" ref-type="bibr">55</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">0.570 (0.386 to 0.737)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> GHQ-20 (<xref rid="pkae031-B56" ref-type="bibr">56</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">204</td><td rowspan="1" colspan="1">0.314 (0.254 to 0.381)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> GHQ-30 (<xref rid="pkae031-B57" ref-type="bibr">57</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1">0.150 (0.099 to 0.221)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Hornheide Questionnaire (<xref rid="pkae031-B58" ref-type="bibr">58</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">0.188 (0.102 to 0.322)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Insomnia</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">667</td><td rowspan="1" colspan="1">0.438 (0.358 to 0.522)</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">.63</td></tr><tr><td rowspan="1" colspan="1"> PSQI (<xref rid="pkae031-B59" ref-type="bibr">59</xref>)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">667</td><td rowspan="1" colspan="1">0.438 (0.358 to 0.522)</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">.63</td></tr><tr><td rowspan="1" colspan="1"> Posttraumatic stress disorder</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">0.177 (0.061 to 0.413)</td><td rowspan="1" colspan="1">61.5</td><td rowspan="1" colspan="1">.07</td></tr><tr><td rowspan="1" colspan="1"> PCL-C (<xref rid="pkae031-B60" ref-type="bibr">60</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">93</td><td rowspan="1" colspan="1">0.118 (0.067 to 0.201)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> PSS-SR (<xref rid="pkae031-B61" ref-type="bibr">61</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">65</td><td rowspan="1" colspan="1">0.190 (0.112 to 0.304)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> IES-R (<xref rid="pkae031-B62" ref-type="bibr">62</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">0.320 (0.161 to 0.535)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p>ASDS = Acute Stress Disorder Scale; BAI = Beck Anxiety Inventory; BDI = Beck Depression Inventory; BDI-FS = Beck Depression Inventory&#8211;Fast Screen; BSI-18 = Brief Symptom Inventory&#8211;18; CES-D = Center for Epidemiological Studies Depression Scale; CI = confidence interval; DS = Depressive Scale; DT = Distress Thermometer; ESAS = Edmonton Symptom Assessment Symptom; GAD-7 = General Anxiety Disorder&#8211;7; GDS = Geriatric Depression Scale; GHQ = General Health Questionnaire; GSI = Overall Psychological Distress; HADS = Hospital Anxiety and Depression Scale; IES-R = Impact of Events Scale&#8211;Revised; MAAC = Mental Adjustment to Cancer; MAS = Manifest Anxiety Scale; MDI = Major Depression Inventory; Mini-5 = Mini-International Neuropsychiatric Interview; NA = not applicable; PCL-C = Posttraumatic Stress Disorder Checklist&#8211;Civilian Version; PHQ = Patient Health Questionnaire; PSQI = Pittsburgh Sleep Questionnaire Inventory; PSS-SR = Posttraumatic Stress Disorder Scale-Self Report; QIDS-SR = Quick Inventory of Depressive Symptoms-Self-Assessment; SAS = Zung Self-Rating Anxiety Scale; SDS Zung = Self-Rating Depression Scale; STAI = State Trait Anxiety Inventory; WHO-5 = World Health Organization&#8211;Five Well-Being Index.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pkae031-T2" orientation="portrait"><label>Table 2.</label><caption><p>Prevalence of mental disorders across each of the domains and scales studied<xref rid="tblfn2" ref-type="table-fn"><sup>a</sup></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="char" char="." span="1"/><col valign="top" align="center" span="1"/><col valign="top" align="center" span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Diagnostic criteria</th><th rowspan="2" colspan="1">No. studies</th><th rowspan="2" colspan="1">Sample size</th><th rowspan="2" colspan="1">Prevalence (95% CI)</th><th colspan="2" rowspan="1">Heterogeneity<hr/></th></tr><tr><th rowspan="1" colspan="1">
<italic toggle="yes">I</italic>
<sup>2</sup>, %</th><th rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> Depression</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">331&#8202;653</td><td rowspan="1" colspan="1">0.103 (0.079 to 0.133)</td><td rowspan="1" colspan="1">99.5</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> DSM-IV</italic> (<xref rid="pkae031-B63" ref-type="bibr">63</xref>)</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1886</td><td rowspan="1" colspan="1">0.107 (0.068 to 0.163)</td><td rowspan="1" colspan="1">80.0</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> ICD-9</italic> (<xref rid="pkae031-B64" ref-type="bibr">64</xref>)</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">328&#8202;936</td><td rowspan="1" colspan="1">0.091 (0.068 to 0.163)</td><td rowspan="1" colspan="1">99.8</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> ICD-10</italic> (<xref rid="pkae031-B65" ref-type="bibr">65</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">771</td><td rowspan="1" colspan="1">0.149 (0.126 to 0.176)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> SADS (<xref rid="pkae031-B66" ref-type="bibr">66</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">0.200 (0.117 to 0.320)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Anxiety</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">215&#8202;368</td><td rowspan="1" colspan="1">0.056 (0.029 to 0.105)</td><td rowspan="1" colspan="1">99.5</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> DSM-IV</italic> (<xref rid="pkae031-B63" ref-type="bibr">63</xref>)</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">1176</td><td rowspan="1" colspan="1">0.061 (0.028 to 0.131)</td><td rowspan="1" colspan="1">84.7</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> ICD-9</italic> (<xref rid="pkae031-B64" ref-type="bibr">64</xref>)</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">213&#8202;421</td><td rowspan="1" colspan="1">0.048 (0.011 to 0.184)</td><td rowspan="1" colspan="1">99.8</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> ICD-10</italic> (<xref rid="pkae031-B65" ref-type="bibr">65</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">771</td><td rowspan="1" colspan="1">0.120 (0.098 to 0.144)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Insomnia</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">67&#8202;364</td><td rowspan="1" colspan="1">0.096 (0.016 to 0.406)</td><td rowspan="1" colspan="1">99.4</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> DSM-IV</italic> (<xref rid="pkae031-B63" ref-type="bibr">63</xref>)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">433</td><td rowspan="1" colspan="1">0.153 (0.028 to 0.537)</td><td rowspan="1" colspan="1">96.9</td><td rowspan="1" colspan="1">&lt;.01</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> ICD-9</italic> (<xref rid="pkae031-B64" ref-type="bibr">64</xref>)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">66&#8202;931</td><td rowspan="1" colspan="1">0.009 (0.009 to 0.010)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"> Posttraumatic stress disorder</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">344</td><td rowspan="1" colspan="1">0.010 (0.000 to 0.848)</td><td rowspan="1" colspan="1">66.5</td><td rowspan="1" colspan="1">.05</td></tr><tr><td rowspan="1" colspan="1">
<italic toggle="yes"> DSM-IV</italic> (<xref rid="pkae031-B63" ref-type="bibr">63</xref>)</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">344</td><td rowspan="1" colspan="1">0.010 (0.000 to 0.848)</td><td rowspan="1" colspan="1">66.5</td><td rowspan="1" colspan="1">.05</td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><label>a</label><p>CI = confidence interval; <italic toggle="yes">DSM-IV</italic> = <italic toggle="yes">Diagnostic and Statistical Manual of Mental Disorders&#8211;4th Edition</italic>; <italic toggle="yes">ICD</italic> = <italic toggle="yes">International Classification of Diseases</italic>; NA = not applicable; SADS = Schedule for Affective Disorders and Schizophrenia.</p></fn></table-wrap-foot></table-wrap><sec><title>Depression</title><p>Depressive symptoms prevalence was reported in 127 studies, including a total sample of 23&#8202;302 participants. Multiple evaluation scales were used, including Hospital Anxiety and Depression Scale (HADS) Depression Subscale (k&#8201;=&#8201;68) (<xref rid="pkae031-B32" ref-type="bibr">32</xref>), Centre for Epidemiologic Studies Depression Scale (k&#8201;=&#8201;16) (<xref rid="pkae031-B33" ref-type="bibr">33</xref>), Beck Depression Inventory (k&#8201;=&#8201;14) (<xref rid="pkae031-B34" ref-type="bibr">34</xref>), Patient Health Questionnaire&#8211;9 (k&#8201;=&#8201;11) (<xref rid="pkae031-B35" ref-type="bibr">35</xref>), and Zung Self-Rating Depression Scale (k&#8201;=&#8201;2) (<xref rid="pkae031-B37" ref-type="bibr">37</xref>), among others. The pooled prevalence of clinically significant depressive symptoms was 0.195 (95% confidence interval [CI] = 0.173 to 0.218). Prevalence varied widely depending on the scale used, from 0.490 with Mini-International Neuropsychiatric Interview (<xref rid="pkae031-B67" ref-type="bibr">67</xref>) to 0.088 with Depressive Scale (<xref rid="pkae031-B44" ref-type="bibr">44</xref>). The funnel plot and Egger test suggested the presence of a publication bias (<italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;3.83, <italic toggle="yes">P</italic> &lt; .01). After performing trim and fill method corrections, depressive symptoms prevalence meaningfully increased (corrected prevalence = 0.282, 95% CI = 0.249 to 0.317) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1, A</xref>, available online).</p><p>Depressive disorders were assessed using diagnostic interviews, including the <italic toggle="yes">Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</italic> (<italic toggle="yes">DSM-IV</italic>; k&#8201;=&#8201;14) (<xref rid="pkae031-B63" ref-type="bibr">63</xref>), the <italic toggle="yes">International Classification of Diseases</italic>, <italic toggle="yes">Ninth Revision</italic> (<italic toggle="yes">ICD-9</italic>; k&#8201;=&#8201;11) and <italic toggle="yes">Tenth Revision</italic> (<italic toggle="yes">ICD-10</italic>; k&#8201;=&#8201;1) (<xref rid="pkae031-B65" ref-type="bibr">65</xref>,<xref rid="pkae031-B68" ref-type="bibr">68</xref>), and the Schedule for Affective Disorder and Schizophrenia (k&#8201;=&#8201;1) (<xref rid="pkae031-B66" ref-type="bibr">66</xref>), in 27 articles encompassing 331&#8202;653 patients. The pooled prevalence of depression disorder was 0.103 (95% CI = 0.079 to 0.133) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2, A</xref>, available online). Again, prevalence varied depending on the scale used, from 0.596 with Schedule for Affective Disorder and Schizophrenia to 0.091 with <italic toggle="yes">ICD-9</italic>. No evidence of publication bias was found (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1, B</xref>, available online).</p><p>Subgroup and meta-regression analyses revealed no statistically significant differences for any of the studied variables or for depressive symptoms or for depressive disorders (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables 6 and 7</xref>, available online respectively).</p></sec><sec><title>Anxiety</title><p>Anxiety symptom prevalence was examined in 80 studies, involving a total of 10&#8202;478 participants. Various assessment scales were employed, such as the HADS Anxiety Subscale (k&#8201;=&#8201;66) (<xref rid="pkae031-B32" ref-type="bibr">32</xref>), the Generalized Anxiety Disorder Assessment&#8211;7; k&#8201;=&#8201;3) (<xref rid="pkae031-B47" ref-type="bibr">47</xref>), the State-Trait Anxiety Inventory (k&#8201;=&#8201;4) (<xref rid="pkae031-B48" ref-type="bibr">48</xref>), and the Zung Self-Rating Anxiety Scale (k&#8201;=&#8201;2) (<xref rid="pkae031-B50" ref-type="bibr">50</xref>), among others. The pooled prevalence of clinically significant anxiety symptoms was 0.178 (95% CI = 0.145 to 0.215), ranging from 0.596 when using the Zung Self-Rating Anxiety Scale to 0.082 with the Generalized Anxiety Disorder Assessment&#8211;7. Meta-regressions found statistically significant lower prevalence of anxiety symptoms in samples where more people underwent surgical procedures (&#946; = &#8722;0.685, 95% CI = &#8722;1.367 to &#8722;0.003) and laryngectomy (&#946; = &#8722;1.279, 95% CI = &#8722;2.205 to &#8722;0.353), whereas higher prevalence of symptoms were found in samples where more people underwent primary chemoradiation (&#946; = 1.138, 95% CI = 0.169 to 2.107) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 6</xref>, available online). No evidence of publication bias was found (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1, C</xref>, available online).</p><p>Anxiety disorders were assessed using <italic toggle="yes">DSM-IV</italic> (k&#8201;=&#8201;8), <italic toggle="yes">ICD-9</italic> (k&#8201;=&#8201;6), and <italic toggle="yes">ICD-10</italic> (k&#8201;=&#8201;1) in 15 studies, including a total of 215&#8202;368 patients with head and neck cancer. Their pooled prevalence was 0.056 (95% CI = 0.029 to 0.105) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2, B</xref>, available online). Prevalence of these disorders presented statistically significant variations according to when the assessment was performed, with higher prevalence of anxiety disorders before the onset of the oncological treatment (pooled prevalence 0.103, 95% CI = 0.054 to 0.190) and more than 1 year after the treatment had finished (pooled prevalence 0.178, 95% CI = 0.011 to 0.812) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 7</xref>, available online). Meta-regressions revealed no statistically significant differences for any of the studied variables. No evidence of publication bias was found (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1, D</xref>, available online).</p></sec><sec><title>Distress</title><p>Prevalence of distress symptoms was reported in 38 studies, encompassing a total of 5057 participants. Multiple assessment scales were used, including the HADS total score (k&#8201;=&#8201;16) (<xref rid="pkae031-B32" ref-type="bibr">32</xref>), the Distress Thermometer (k&#8201;=&#8201;16) (<xref rid="pkae031-B52" ref-type="bibr">52</xref>), the Adapted Symptom Distress Scale (k&#8201;=&#8201;1) (<xref rid="pkae031-B53" ref-type="bibr">53</xref>), and different versions of the General Health Questionnaire (k&#8201;=&#8201;1) (<xref rid="pkae031-B55" ref-type="bibr">55</xref>). The combined prevalence of clinically significant distress symptoms was 0.343 (95% CI = 0.298 to 0.390), ranging from 0.570 with General Health Questionnaire&#8211;12 to 0.120 with Adapted Symptom Distress Scale (<xref rid="pkae031-F3" ref-type="fig">Figure 3</xref>; <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2, H</xref>, available online). Meta-regressions found statistically significant higher prevalence of distress among samples with higher rates of tobacco use (&#946; = 1.659, 95% CI = 0.290 to 3.027) and advanced stages (&#946; = 1.283, 95% CI = 0.177 to 2.389). Samples with more females (&#946; = &#8722;2.519, 95% CI = &#8722;4.170 to &#8722;0.869), more patients with higher levels of education (&#946; = &#8722;3.703, 95% CI = &#8722;6.894 to &#8722;0.512), and earlier stages of the disease (&#946; = &#8722;1.823, 95% CI = &#8722;2.884 to &#8722;0.762) presented lower prevalence of distress (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 6</xref>, available online). Prevalence of distress presented statistically significant variations according to the continent of the sample (with European samples presenting the lowest prevalence of distress at 0.304 [95% CI = 0.254 to 0.359]) and the timing of the assessment (with distress decreasing as time from diagnosis and treatment passed) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 7</xref>, available online). No evidence of publication bias was found (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1, E</xref>, available online).</p><fig position="float" id="pkae031-F3" orientation="portrait"><label>Figure 3.</label><caption><p>Forest plot for clinically significant distress. CI = confidence interval. </p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pkae031f3.jpg"/></fig></sec><sec><title>Insomnia</title><p>Insomnia-related relevant symptoms were assessed in 3 studies (n&#8201;=&#8201;667 patients) using the Pittsburgh Sleep Quality Index (<xref rid="pkae031-B59" ref-type="bibr">59</xref>), with a pooled prevalence of 0.438 (95% CI = 0.358 to 0.522). Insomnia disorder was also assessed in 6 studies (n&#8201;=&#8201;67&#8202;364 patients) using <italic toggle="yes">DSM-IV</italic> (k&#8201;=&#8201;5) and <italic toggle="yes">ICD-9</italic> (k&#8201;=&#8201;1), with an overall prevalence of 0.096 (95% CI = 0.016 to 0.406) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures 2, C and D</xref>, available online). Not enough data were available to perform any meta-regression or subgroup analysis.</p></sec><sec><title>Posttraumatic symptoms and disorder</title><p>Posttraumatic symptoms were studied in 3 studies, with a total sample size of 180 patients and a pooled prevalence of 0.177 (95% CI = 0.061 to 0.413), while posttraumatic stress disorder was assessed in 3 studies (n&#8201;=&#8201;344) using <italic toggle="yes">DSM-IV</italic>, with an overall prevalence of 0.010 (95% CI = 0.000 to 0.848) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2, E and F</xref>, available online). Not enough data were available to perform any meta-regression or subgroup analysis.</p></sec><sec><title>Suicide</title><p>Suicide incidence among patients with head and neck cancer was reported in 4 studies, including a total of 1&#8202;976&#8202;569 person-years (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table 5</xref>, available online). Overall pooled incidence of suicide was 161.16 suicides per 100&#8202;000 individuals per year (95% CI = 82.88 to 239.43) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2, G</xref>, available online). Not enough data were available to meta-analyze the standardized mortality risk or any other relative risk outcome.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>This is the first systematic review and meta-analysis to date to comprehensively assess the prevalence of mental health symptoms and disorders among patients with head and neck cancer.</p><p>In our study, 19.5% of patients with head and neck cancer were found to report clinically significant depressive symptoms through self-reported scales, a percentage that decreased to 10.3% when considering diagnosed depressive disorders through clinical interviews. These findings closely align with those reported by Krebber et al. (<xref rid="pkae031-B24" ref-type="bibr">24</xref>) in a meta-analysis that encompassed samples of cancer patients with various primary tumor types and far surpass the prevalence of major depression disorders observed in the general population, which hover around 4% (<xref rid="pkae031-B69" ref-type="bibr">69</xref>). Surprisingly, in our meta-analysis the prevalence of depressive symptoms or disorders does not appear to be influenced by variables such as tumor location, tumor stage, treatment type, or even well-known depression-inducing factors like tobacco (<xref rid="pkae031-B70" ref-type="bibr">70</xref>) or alcohol (<xref rid="pkae031-B71" ref-type="bibr">71</xref>) consumption. There are several possible explanations for these findings. Depression is a complex mental disorder that can be influenced by individual factors and external circumstances (<xref rid="pkae031-B72" ref-type="bibr">72</xref>), with many of them being idiosyncratic to the individual: genetic factors (<xref rid="pkae031-B73" ref-type="bibr">73</xref>), coping styles and distorted thinking patterns (<xref rid="pkae031-B74" ref-type="bibr">74</xref>), traumatic life events (<xref rid="pkae031-B75" ref-type="bibr">75</xref>), or lack of support systems (<xref rid="pkae031-B76" ref-type="bibr">76</xref>), among many others. Moreover, depression takes a notable time to develop [and to be considered as a disorder, according to <italic toggle="yes">DSM</italic> (<xref rid="pkae031-B77" ref-type="bibr">77</xref>) and <italic toggle="yes">ICD</italic> (<xref rid="pkae031-B68" ref-type="bibr">68</xref>)], which could help explain why depressive symptoms could be less prone to be triggered by external factors.</p><p>Anxiety symptoms appeared to be clinically significant in 17.8% of the patients with head and neck cancer, whereas 5.6% met criteria for an anxiety disorder. The prevalence of anxious symptoms was positively correlated with primary chemoradiation and negatively correlated surgical procedures and laryngectomy. Although surgical procedures in general (<xref rid="pkae031-B78" ref-type="bibr">78</xref>) and laryngectomy in particular (<xref rid="pkae031-B79" ref-type="bibr">79</xref>) have been described as highly distressing procedures, our results could be indirectly reflecting the underlying overall prognosis of the sample (<xref rid="pkae031-B80" ref-type="bibr">80</xref>). Surgical approaches, especially highly invasive procedures like laryngectomy, are typically reserved for patients who are generally fitter and have a better prognosis. Conversely, patients treated with primary chemoradiation tend to have more advanced tumor stages (which contraindicate surgery) and poorer overall health (<xref rid="pkae031-B81" ref-type="bibr">81-83</xref>). Therefore, we believe that the results of our study may reflect that higher levels of anxiety are associated with an unfavorable prognosis. The results of our meta-analysis regarding distress appear to support this hypothesis. The pooled prevalence of distress in the sample is 34.3%, with higher stress levels in advanced tumor stages and lower levels as the measurement moves further from diagnosis and treatment. Interestingly, European samples exhibited a significantly lower distress prevalence compared with those from other continents. Although this may be influenced by various factors, this phenomenon may be related to financial toxicity, defined as the direct and indirect costs associated with cancer diagnosis, treatment, and care (<xref rid="pkae031-B84" ref-type="bibr">84</xref>). In Europe, predominantly publicly funded health-care systems often shield patients from catastrophic medical expenses while also providing effective treatments and overall care (<xref rid="pkae031-B85" ref-type="bibr">85</xref>).</p><p>As for insomnia, the prevalence of symptoms was 43.8%, with 9.6% of the sample meeting criteria for a disorder. Sleep disturbances are a common complaint among patients with head and neck cancer (<xref rid="pkae031-B86" ref-type="bibr">86</xref>), often associated with pain (<xref rid="pkae031-B87" ref-type="bibr">87</xref>), xerostomia (<xref rid="pkae031-B88" ref-type="bibr">88</xref>), and radiation therapy&#8211;related obstructive sleep apnea (<xref rid="pkae031-B89" ref-type="bibr">89</xref>). Insomnia is closely linked to quality of life (<xref rid="pkae031-B90" ref-type="bibr">90</xref>), anxiety (<xref rid="pkae031-B91" ref-type="bibr">91</xref>), depression (<xref rid="pkae031-B92" ref-type="bibr">92</xref>), and alcohol consumption (<xref rid="pkae031-B93" ref-type="bibr">93</xref>). Many of its causal factors are potentially modifiable, making it a promising target for improving the mental health of patients with head and neck cancer. Regarding posttraumatic symptoms, 17.7% exhibited clinically significant symptoms, although the pooled prevalence of posttraumatic stress disorder was approximately 1%. Unfortunately, the wide confidence intervals in the latter outcome do not allow for reliable conclusions.</p><p>Finally, the overall incidence of suicide in the analyzed sample was 161.16 suicides per 100&#8202;000 individuals per year. Suicide is a complex phenomenon influenced by individual, cultural, religious, economic, and health-care access factors (<xref rid="pkae031-B94" ref-type="bibr">94</xref>). Therefore, explaining its fluctuations through a single event such as cancer is challenging. Furthermore, 2 of the samples included in this meta-analysis come from specific populations with a high risk of bias because of the relationship with high rates of suicide: war veterans (<xref rid="pkae031-B95" ref-type="bibr">95</xref>) and the elderly population (<xref rid="pkae031-B96" ref-type="bibr">96</xref>). However, and although we did not obtain sufficient data to analyze standardized mortality ratios or relative risks, all data point to the incidence of suicide in patients with head and neck cancer being higher than that in the general population (<xref rid="pkae031-B12" ref-type="bibr">12</xref>) and other cancer patients (<xref rid="pkae031-B97" ref-type="bibr">97</xref>).</p><p>The conclusions drawn from these findings are manifold. It is evident that head and neck cancers meaningfully impact the mental health of those affected, extending across multiple domains, as our findings point out. However, it is noteworthy that the prevalence of clinically relevant symptoms is much higher compared with the prevalence of criterion-meeting mental disorders for all the studied domains. Self-reported questionnaires could provide an overestimation of the actual percentage of patients with a psychiatric disorder among this population, as previous studies on this field corroborate (<xref rid="pkae031-B24" ref-type="bibr">24</xref>). Indeed, most measures of depression or anxiety severity are based on the number of reported symptoms, with threshold scores often used to classify individuals as healthy or ill. This would be valid if depression, or anxiety, were single conditions and all their symptoms equally good severity indicators. However, specific symptoms like concentration problems, insomnia, or anhedonia are distinct phenomena differing from each other in dimensions such as their biological mechanisms or risk factors (<xref rid="pkae031-B98" ref-type="bibr">98</xref>). Reporting specific symptom profiles among cancer patients, instead of disorders as dichotomic variables, could provide valuable information on their causes, their relationship with the underlying oncological process, and best ways to address them.</p><p>Systematic assessment of mental health should be an integral part of oncological care in patients with head and neck cancer, much like the assessment of pain or other physical discomfort, for which we suggest a stepped-care approach. Self-reported questionnaires can be an effective initial screening tool to identify patients with clinically significant symptoms (<xref rid="pkae031-B99" ref-type="bibr">99</xref>). Systematic screening for emotional distress in patients with some cancer types, in addition to present evidence in the early detection of mental disorders (<xref rid="pkae031-B100" ref-type="bibr">100</xref>), promotes equal access to psychological services, in contrast with a referral system solely reliant on the initiative of doctors or patients (<xref rid="pkae031-B101" ref-type="bibr">101</xref>).</p><p>For those patients who exhibit such distress, the evaluation should be completed with a detailed interview to determine if they indeed present a mental disorder in which case they should be referred to the appropriate specialist for the necessary psychotherapeutic and/or pharmacological treatment at the earliest stages. As for patients experiencing evident symptoms but who do not meet criteria for a disorder, close monitoring of symptoms is recommended. Additionally, group psychotherapeutic approaches have shown strong evidence in alleviating distress in oncologic patient samples while maintaining cost-effectiveness (<xref rid="pkae031-B102" ref-type="bibr">102</xref>,<xref rid="pkae031-B103" ref-type="bibr">103</xref>).</p><p>Notwithstanding all the above, future research should aim to study this subgroup of patients with subclinical mental health impairment to characterize their prognosis and trajectories, along with the effectivity of preventive and therapeutic interventions.</p><p>This study has several important strengths. To the best of the authors&#8217; knowledge, it represents the most extensive meta-analysis to date concerning mental health outcomes in patients with head and neck cancer. Moreover, it explores facets of mental health that have received less attention in prior literature, such as insomnia or suicide. Additionally, it categorizes the evidence into 2 important categories&#8212;symptoms and disorders&#8212;thus facilitating valuable comparisons between the 2 concepts. The inclusion of samples from more than 29 countries spanning 6 continents ensures high generalizability.</p><p>The findings of this study must be interpreted in light of certain limitations; the primary limitation is the substantial heterogeneity among the assessed outcomes. Various scales have been employed to evaluate each domain, assessing slightly different aspects of each mental health outcome and using different cutoff points. The populations within each study exhibit varying frequencies, reflecting the heterogeneity observed in head and neck cancers, as well as different stages of the disease. Most of the included studies do not provide stratified data for each primary location or type of treatment, which is why the effect of these variables could only be analyzed through meta-regressions, which could incur into ecological bias (<xref rid="pkae031-B104" ref-type="bibr">104</xref>). There was not enough data about psychiatric antecedents and drug use to study their influence either. Furthermore, the cross-sectional nature of the included measurements limits our understanding of the evolution of mental health outcomes throughout the oncological process. In studies that analyze long-term survivors, we cannot rule out the presence of survival bias. Future studies should longitudinally assess the evolution of emotional distress to identify the most intervention-sensitive points.</p><p>Our findings reveal that patients with head and neck cancer are particularly vulnerable to a spectrum of mental health symptoms and disorders, with great proportions of them experiencing depressive symptoms, anxiety, distress, insomnia, posttraumatic symptoms, and even suicide. Self-reported questionnaires, however, could provide an overestimation of the prevalence of disorders among this population. Future research should focus on longitudinal evaluations to identify intervention-sensitive points and develop targeted interventions that enhance the mental health and quality of life of individuals facing head and neck cancer.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data" orientation="portrait"><label>pkae031_Supplementary_Data</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pkae031_supplementary_data.zip" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="ack1"><title>Acknowledgements </title><p>This research received funding from the OSI Bilbao-Basurto Research Commission for publication fees.</p></ack><sec sec-type="data-availability"><title>Data availability</title><p>The data that support the findings of this study are available from the corresponding author, PJL, on reasonable request.</p></sec><sec><title>Author contributions</title><p>Pablo Jim&#233;nez Labaig, MD (Conceptualization; Formal analysis; Methodology; Writing &#8211; original draft; Writing &#8211; review &amp; editing), Claudia Aymerich, MD (Conceptualization; Data curation; Investigation; Writing &#8211; original draft; Writing &#8211; review &amp; editing), Irene Bra&#241;a, MD, PhD (Methodology; Writing &#8211; review &amp; editing), Antonio Rullan, MD, PhD (Methodology; Supervision; Writing &#8211; review &amp; editing), Jon Cacicedo, MD (Conceptualization; Methodology), Miguel Angel Gonz&#225;lez-Torres, MD, PhD (Methodology; Supervision), Kevin Harrington, MD, PhD, MBBS (Conceptualization; Methodology; Supervision), and Ana Catalan, MD, PhD (Conceptualization; Methodology; Supervision).</p></sec><sec><title>Funding</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>PJ received personal fees or grants from Roche, Merck, MSD Merck Sharp &amp; Dohme, and Novartis outside the current work. CA received personal fees or grants from Janssen Cilag and Neuraxpharm outside the current work. IB received personal fees from Merck sharp &amp; Dohme, Sanofi, Achilles Therapeutics, eTheRNA Immunotherapies, Cancer Expert Now, Boehringer Ingelheim as a Speakers&#8217; Bureau: Bristol Myers Squibb, Merck Serono, Roche, MSD. Lastly, as a research funding: AstraZeneca (Inst), Bristol Myers Squibb (Inst), Celgene (Inst), Gliknik (Inst), GlaxoSmithKline (Inst), Janssen Oncology (Inst), Kura Oncology (Inst), Merck Sharp &amp; Dohme (Inst), Novartis (Inst), Pfizer (Inst), Roche (Inst), Shattuck labs (Inst), Nanobiotix (Inst), Seattle Genetics (Inst), Immutep (Inst), Debiopharm Group (Inst), Regeneron (Inst), Boehringer Ingelheim (Inst), ISA Pharmaceuticals (Inst), Merck Serono (Inst), Seattle Genetics (Inst), Northern Biologics (Inst), VCN Biosciences (Inst), and for travel, accommodations and expenses: MSD Oncology. KJH received honoraria from Arch Oncology (Inst), AstraZeneca (Inst), BMS (Inst), Boehringer Ingelheim (Inst), Merck Serono (Inst), MSD (Inst), Oncolys Biopharma (Inst), Pfizer (Inst), Replimune (Inst), Inzen Therapeutics (Inst) and Codiak Biosciences (Inst). Consulting or Advisory Role: Arch Oncology (Inst), AstraZeneca (Inst), BMS (Inst), Boehringer Ingelheim (Inst), Merck Serono (Inst), MSD (Inst), Oncolys BioPharma (Inst), Replimune (Inst), Inzen Therapeutics (Inst) Speakers&#8217; Bureau: BMS (Inst), Merck Serono (Inst), MSD (Inst) Research Funding: AstraZeneca (Inst), Merck Sharp &amp; Dohme (Inst), Replimune (Inst), Boehringer Ingelheim (Inst). AC received personal fees or grants from Janssen Cilag, ROVI, and Lundbeck outside the current work. All other authors have declared no conflicts of interest.</p></sec><ref-list id="ref1"><title>References</title><ref id="pkae031-B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sung</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. <year>2021</year>;<volume>71</volume>(<issue>3</issue>):<fpage>209</fpage>-<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>.<pub-id pub-id-type="pmid">33538338</pub-id></mixed-citation></ref><ref id="pkae031-B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Johnson</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Burtness</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Leemans</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Lui</surname><given-names>VWY</given-names></string-name>, <string-name name-style="western"><surname>Bauman</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Grandis</surname><given-names>JR.</given-names></string-name></person-group><article-title>Head and neck squamous cell carcinoma</article-title>. <source>Nat Rev Dis Primers</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<fpage>92</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41572-020-00224-3</pub-id>.<pub-id pub-id-type="pmid">33243986</pub-id><pub-id pub-id-type="pmcid">PMC7944998</pub-id></mixed-citation></ref><ref id="pkae031-B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gascon</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Panjwani</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Mazzurco</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>M.</given-names></string-name></person-group><article-title>Screening for distress and health outcomes in head and neck cancer</article-title>. <source>Curr Oncol</source>. <year>2022</year>;<volume>29</volume>(<issue>6</issue>):<fpage>3793</fpage>-<lpage>3806</lpage>. doi:<pub-id pub-id-type="doi">10.3390/curroncol29060304</pub-id>.<pub-id pub-id-type="pmid">35735413</pub-id><pub-id pub-id-type="pmcid">PMC9221700</pub-id></mixed-citation></ref><ref id="pkae031-B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nayak</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sharan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Chakrabarty</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Devi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ravishankar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>George</surname><given-names>A.</given-names></string-name></person-group><article-title>Psychosocial distress of head neck cancer (HNC) patients receiving radiotherapy: a systematic review</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2022</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1827</fpage>-<lpage>1835</lpage>. doi:<pub-id pub-id-type="doi">10.31557/APJCP.2022.23.6.1827</pub-id>.<pub-id pub-id-type="pmid">35763621</pub-id><pub-id pub-id-type="pmcid">PMC9587841</pub-id></mixed-citation></ref><ref id="pkae031-B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ruud Kj&#230;r</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Jensen</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Jakobsen</surname><given-names>KK</given-names></string-name></person-group>, <etal>et al</etal><article-title>The impact of comorbidity on survival in patients with head and neck squamous cell carcinoma: a nationwide case-control study spanning 35 years</article-title>. <source>Front Oncol</source><year>2020</year>;<volume>10</volume>:<fpage>617184</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2020.617184</pub-id>.<pub-id pub-id-type="pmid">33680938</pub-id><pub-id pub-id-type="pmcid">PMC7928275</pub-id></mixed-citation></ref><ref id="pkae031-B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Taylor</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Terrell</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Ronis</surname><given-names>DL</given-names></string-name></person-group>, <etal>et al</etal>; <collab>University of Michigan Head and Neck Cancer Team</collab>. <article-title>Disability in patients with head and neck cancer</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2004</year>;<volume>130</volume>(<issue>6</issue>):<fpage>764</fpage>-<lpage>769</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archotol.130.6.764</pub-id>.<pub-id pub-id-type="pmid">15210560</pub-id></mixed-citation></ref><ref id="pkae031-B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brook</surname><given-names>I.</given-names></string-name></person-group><article-title>Late side effects of radiation treatment for head and neck cancer</article-title>. <source>Radiat Oncol J</source>. <year>2020</year>;<volume>38</volume>(<issue>2</issue>):<fpage>84</fpage>-<lpage>92</lpage>. doi:<pub-id pub-id-type="doi">10.3857/roj.2020.00213</pub-id>.<pub-id pub-id-type="pmid">33012151</pub-id><pub-id pub-id-type="pmcid">PMC7533405</pub-id></mixed-citation></ref><ref id="pkae031-B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Henry</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Albert</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Frenkiel</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Body image concerns in patients with head and neck cancer: a longitudinal study</article-title>. <source>Front Psychol</source>. <year>2022</year>;<volume>13</volume>:<fpage>816587</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2022.816587</pub-id>.<pub-id pub-id-type="pmid">35401366</pub-id><pub-id pub-id-type="pmcid">PMC8988682</pub-id></mixed-citation></ref><ref id="pkae031-B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>So</surname><given-names>WKW</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>DNS</given-names></string-name></person-group>, <etal>et al</etal><article-title>Quality-of-life among head and neck cancer survivors at one year after treatment&#8212;a systematic review</article-title>. <source>European Journal of Cancer (1990)</source>. <year>2012</year>;<volume>48</volume>(<issue>15</issue>):<fpage>2391</fpage>-<lpage>2408</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejca.2012.04.005</pub-id>.<pub-id pub-id-type="pmid">22579456</pub-id></mixed-citation></ref><ref id="pkae031-B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hammerm&#252;ller</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hinz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Dietz</surname><given-names>A</given-names></string-name></person-group>, <etal>et al</etal><article-title>Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population</article-title>. <source>BMC Cancer</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>94</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12885-020-07773-6</pub-id>.<pub-id pub-id-type="pmid">33482771</pub-id><pub-id pub-id-type="pmcid">PMC7825198</pub-id></mixed-citation></ref><ref id="pkae031-B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname><given-names>C</given-names></string-name></person-group>, <etal>et al</etal><article-title>Anxiety and depression in patients with head and neck cancer: 6-month follow-up study</article-title>. <source>Neuropsychiatr Dis Treat</source>. <year>2016</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1029</fpage>-<lpage>1036</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NDT.S103203</pub-id>.<pub-id pub-id-type="pmid">27175080</pub-id><pub-id pub-id-type="pmcid">PMC4854266</pub-id></mixed-citation></ref><ref id="pkae031-B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Misono</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Fann</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Redman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yueh</surname><given-names>B.</given-names></string-name></person-group><article-title>Incidence of suicide in persons with cancer</article-title>. <source>J Clin Oncol</source>. <year>2008</year>;<volume>26</volume>(<issue>29</issue>):<fpage>4731</fpage>-<lpage>4738</lpage>. doi:<pub-id pub-id-type="doi">10.1200/JClinOncol.2007.13.8941</pub-id>.<pub-id pub-id-type="pmid">18695257</pub-id><pub-id pub-id-type="pmcid">PMC2653137</pub-id></mixed-citation></ref><ref id="pkae031-B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koo</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Swann</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>McPhail</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Presenting symptoms of cancer and stage at diagnosis: Evidence from a cross-sectional, population-based study</article-title>. <source>Lancet Oncol</source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<fpage>73</fpage>-<lpage>79</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1470-2045(19)30595-9</pub-id>.<pub-id pub-id-type="pmid">31704137</pub-id><pub-id pub-id-type="pmcid">PMC6941215</pub-id></mixed-citation></ref><ref id="pkae031-B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Al Maqbali</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Al Sinani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Al Naamani</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Al Badi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tanash</surname><given-names>MI.</given-names></string-name></person-group><article-title>Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis</article-title>. <source>J Pain Symptom Manage</source>. <year>2021</year>;<volume>61</volume>(<issue>1</issue>):<fpage>167</fpage>-<lpage>189.e14</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpainsymman.2020.07.037</pub-id>.<pub-id pub-id-type="pmid">32768552</pub-id></mixed-citation></ref><ref id="pkae031-B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Niedzwiedz</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Knifton</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Robb</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Katikireddi</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>DJ.</given-names></string-name></person-group><article-title>Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority</article-title>. <source>BMC Cancer</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>943</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12885-019-6181-4</pub-id>.<pub-id pub-id-type="pmid">31604468</pub-id><pub-id pub-id-type="pmcid">PMC6788022</pub-id></mixed-citation></ref><ref id="pkae031-B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Smith</surname><given-names>HR.</given-names></string-name></person-group><article-title>Depression in cancer patients: pathogenesis, implications and treatment (review)</article-title>. <source>Oncol Lett</source>. <year>2015</year>;<volume>9</volume>(<issue>4</issue>):<fpage>1509</fpage>-<lpage>1514</lpage>. doi:<pub-id pub-id-type="doi">10.3892/ol.2015.2944</pub-id>.<pub-id pub-id-type="pmid">25788991</pub-id><pub-id pub-id-type="pmcid">PMC4356432</pub-id></mixed-citation></ref><ref id="pkae031-B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Duffy</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Terrell</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Valenstein</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ronis</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Copeland</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Connors</surname><given-names>M.</given-names></string-name></person-group><article-title>Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients</article-title>. <source>Gen Hosp Psychiatry</source>. <year>2002</year>;<volume>24</volume>(<issue>3</issue>):<fpage>140</fpage>-<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0163-8343(02)00180-9</pub-id>.<pub-id pub-id-type="pmid">12062138</pub-id></mixed-citation></ref><ref id="pkae031-B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Macias</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hand</surname><given-names>BN</given-names></string-name>, <string-name name-style="western"><surname>Pipkorn</surname><given-names>P</given-names></string-name></person-group>, <etal>et al</etal><article-title>Association of inventory to measure and assess imaGe disturbance&#8212;head and neck scores with clinically meaningful body image-related distress among head and neck cancer survivors</article-title>. <source>Front Psychol</source>. <year>2021</year>;<volume>12</volume>:<fpage>794038</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2021.794038</pub-id>.<pub-id pub-id-type="pmid">34956022</pub-id><pub-id pub-id-type="pmcid">PMC8702522</pub-id></mixed-citation></ref><ref id="pkae031-B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lewis</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pandey</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Salins</surname><given-names>N</given-names></string-name></person-group>, <etal>et al</etal><article-title>Distress screening in head and neck cancer patients planned for Cancer&#8208;Directed radiotherapy</article-title>. <source>Laryngoscope</source>. <year>2021</year>;<volume>131</volume>(<issue>9</issue>):<fpage>2023</fpage>-<lpage>2029</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.29491</pub-id>.<pub-id pub-id-type="pmid">33720420</pub-id></mixed-citation></ref><ref id="pkae031-B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Geng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>Y</given-names></string-name></person-group>, <etal>et al</etal><article-title>Survey of mental health effects among health care workers involved with the COVID-19 outbreak</article-title>. <source>Iran J Public Health</source>. <year>2020</year>;<volume>49</volume>(<issue>11</issue>):<fpage>2214</fpage>-<lpage>2216</lpage>. doi:<pub-id pub-id-type="doi">10.18502/ijph.v49i11.4740</pub-id> [doi].<pub-id pub-id-type="pmid">33708743</pub-id><pub-id pub-id-type="pmcid">PMC7917510</pub-id></mixed-citation></ref><ref id="pkae031-B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Krauss</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Keszte</surname><given-names>J</given-names></string-name></person-group>, <etal>et al</etal><article-title>Predictors of emotional distress in patients with head and neck cancer</article-title>. <source>Head &amp; Neck</source>. <year>2012</year>;<volume>34</volume>(<issue>2</issue>):<fpage>180</fpage>-<lpage>187</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hed.21702</pub-id>.<pub-id pub-id-type="pmid">21400629</pub-id></mixed-citation></ref><ref id="pkae031-B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Madrigal</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tie</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Verma</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Benharash</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rapkin</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>St John</surname><given-names>MA.</given-names></string-name></person-group><article-title>The increasing burden of depression in patients undergoing head and neck cancer operations</article-title>. <source>Laryngoscope</source>. <year>2023</year>;<volume>133</volume>(<issue>12</issue>):<fpage>3396</fpage>-<lpage>3402</lpage>., doi:<pub-id pub-id-type="doi">10.1002/lary.30735</pub-id>.<pub-id pub-id-type="pmid">37161918</pub-id></mixed-citation></ref><ref id="pkae031-B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rohde</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Adjei Boakye</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Challapalli</surname><given-names>SD</given-names></string-name></person-group>, <etal>et al</etal><article-title>Prevalence and sociodemographic factors associated with depression among hospitalized patients with head and neck cancer&#8212;Results from a national study</article-title>. <source>Psychooncology</source>. <year>2018</year>;<volume>27</volume>(<issue>12</issue>):<fpage>2809</fpage>-<lpage>2814</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.4893</pub-id>.<pub-id pub-id-type="pmid">30225960</pub-id></mixed-citation></ref><ref id="pkae031-B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Krebber</surname><given-names>AMH</given-names></string-name>, <string-name name-style="western"><surname>Buffart</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Kleijn</surname><given-names>G</given-names></string-name></person-group>, <etal>et al</etal><article-title>Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments</article-title>. <source>Psycho-Oncology</source>. <year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>121</fpage>-<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.3409</pub-id>.<pub-id pub-id-type="pmid">24105788</pub-id><pub-id pub-id-type="pmcid">PMC4282549</pub-id></mixed-citation></ref><ref id="pkae031-B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liberati</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name></person-group>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>151</volume>(<issue>4</issue>):<fpage>264</fpage>-<lpage>269, W64</lpage>. doi:0000605-200908180-00135 [pii].<pub-id pub-id-type="pmid">19622511</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-151-4-200908180-00135</pub-id></mixed-citation></ref><ref id="pkae031-B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stroup</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Berlin</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Morton</surname><given-names>SC</given-names></string-name></person-group>, <etal>et al</etal><article-title>Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group</article-title>. <source>JAMA</source>. <year>2000</year>;<volume>283</volume>(<issue>15</issue>):<fpage>2008</fpage>-<lpage>2012</lpage>. doi:Jst00003 [pii].<pub-id pub-id-type="pmid">10789670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.283.15.2008</pub-id></mixed-citation></ref><ref id="pkae031-B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Simera</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hoey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schulz</surname><given-names>K.</given-names></string-name></person-group><article-title>EQUATOR: Reporting guidelines for health research</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>(<issue>9619</issue>):<fpage>1149</fpage>-<lpage>1150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(08)60505-X</pub-id>.<pub-id pub-id-type="pmid">18395566</pub-id></mixed-citation></ref><ref id="pkae031-B28"><label>28</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Wells</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Shea</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Connell</surname><given-names>D</given-names></string-name></person-group>, <etal>et al</etal><italic toggle="yes">The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analyses</italic>. <year>2012</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wwwohrica/programs/clinical_epidemiology/oxfordasp" ext-link-type="uri">http://wwwohrica/programs/clinical_epidemiology/oxfordasp</ext-link>. Updated 2012, 2021. Accessed July 1, 2023.</mixed-citation></ref><ref id="pkae031-B29"><label>29</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Lipsey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>D</given-names></string-name></person-group>, <source>Practical Meta-Analysis</source>. <edition>1st ed. CA</edition>: <publisher-loc>Sage</publisher-loc>: <publisher-name>Thousand Oaks</publisher-name>; <year>2001</year>.</mixed-citation></ref><ref id="pkae031-B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Egger</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Schneider</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Minder</surname><given-names>C.</given-names></string-name></person-group><article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>-<lpage>634</lpage>.<pub-id pub-id-type="pmid">9310563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.315.7109.629</pub-id><pub-id pub-id-type="pmcid">PMC2127453</pub-id></mixed-citation></ref><ref id="pkae031-B31"><label>31</label><mixed-citation publication-type="other"><collab>R Foundation for Statistical Computing</collab>. <italic toggle="yes">R: A Language and Environment for Statistical Computing</italic>. <year>2021</year>;1.4.1106. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.r-project.org/" ext-link-type="uri">https://www.r-project.org/</ext-link>. Accessed July 1, 2023.</mixed-citation></ref><ref id="pkae031-B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Snaith</surname><given-names>RP.</given-names></string-name></person-group><article-title>The hospital anxiety and depression scale</article-title>. <source>Health Qual Life Outcomes</source>. <year>2003</year>;<volume>1</volume>:<fpage>29</fpage>-<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1186/1477-7525-1-29</pub-id>.<pub-id pub-id-type="pmid">12914662</pub-id><pub-id pub-id-type="pmcid">PMC183845</pub-id></mixed-citation></ref><ref id="pkae031-B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Radloff</surname><given-names>LS.</given-names></string-name></person-group><article-title>The CES-D scale: a self-report depression scale for research in the general population</article-title>. <source>Appl Psychol Measur</source>. <year>1977</year>;<volume>1</volume>(<issue>3</issue>):<fpage>385</fpage>-<lpage>401</lpage>.</mixed-citation></ref><ref id="pkae031-B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Beck</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Mendelson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mock</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Erbaugh</surname><given-names>J.</given-names></string-name></person-group><article-title>An inventory for measuring depression</article-title>. <source>Arch Gen Psychiatry</source>. <year>1961</year>;<volume>4</volume>:<fpage>561</fpage>-<lpage>571</lpage>.<pub-id pub-id-type="pmid">13688369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1961.01710120031004</pub-id></mixed-citation></ref><ref id="pkae031-B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kroenke</surname><given-names>KSR</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>JB.</given-names></string-name></person-group><article-title>The PHQ-9: validity of a brief depression severity measure</article-title>. <source>J Gen Intern Med</source>. <year>2001</year>;<volume>9</volume>:<fpage>606</fpage>-<lpage>613</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1525-1497.2001.016009606.x</pub-id><pub-id pub-id-type="pmcid">PMC1495268</pub-id><pub-id pub-id-type="pmid">11556941</pub-id></mixed-citation></ref><ref id="pkae031-B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yesavage</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Brink</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Rose</surname><given-names>TL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Development and validation of a geriatric depression screening scale: a preliminary report</article-title>. <source>J Psychiatr Res</source><year>1982</year>;<volume>17</volume>(<issue>1</issue>):<fpage>37</fpage>-<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0022-3956(82)90033-4</pub-id>.<pub-id pub-id-type="pmid">7183759</pub-id></mixed-citation></ref><ref id="pkae031-B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zung</surname><given-names>W.</given-names></string-name></person-group><article-title>Self-rating depression scale</article-title>. <source>Arch Gen Psychiatry</source>. <year>1965</year>;<volume>12</volume>:<fpage>63</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="pmid">14221692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1965.01720310065008</pub-id></mixed-citation></ref><ref id="pkae031-B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Derogatis</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Melisaratos</surname><given-names>N.</given-names></string-name></person-group><article-title>The brief symptom inventory: an introductory report</article-title>. <source>Psychol Med</source>. <year>1983</year>;<volume>13</volume>(<issue>3</issue>):<fpage>595</fpage>-<lpage>605</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291700048017</pub-id>.<pub-id pub-id-type="pmid">6622612</pub-id></mixed-citation></ref><ref id="pkae031-B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rush</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Trivedi</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Ibrahim</surname><given-names>HM</given-names></string-name></person-group>, <etal>et al</etal><article-title>The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression</article-title>. <source>Biol Psychiatry</source>. <year>2003</year>;<volume>54</volume>(<issue>5</issue>):<fpage>573</fpage>-<lpage>583</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-3223(02)01866-8</pub-id>.<pub-id pub-id-type="pmid">12946886</pub-id></mixed-citation></ref><ref id="pkae031-B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vignaroli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pace</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Willey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Palmer</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bruera</surname><given-names>E.</given-names></string-name></person-group><article-title>The edmonton symptom assessment system as a screening tool for depression and anxiety</article-title>. <source>J Palliat Med</source><year>2006</year>;<volume>9</volume>(<issue>2</issue>):<fpage>296</fpage>-<lpage>303</lpage>. doi:<pub-id pub-id-type="doi">10.1089/jpm.2006.9.296</pub-id>.<pub-id pub-id-type="pmid">16629559</pub-id></mixed-citation></ref><ref id="pkae031-B41"><label>41</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Beck</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Steer</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>GK.</given-names></string-name></person-group><italic toggle="yes">BDI&#8212;Fast Screen for Medical Patients.</italic><year>2000</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.apa.org/doi/10.1037/t00742-000" ext-link-type="uri">https://doi.apa.org/doi/10.1037/t00742-000</ext-link>. Accessed August 30, 2023.</mixed-citation></ref><ref id="pkae031-B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Topp</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>&#216;stergaard</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>S&#248;ndergaard</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bech</surname><given-names>P.</given-names></string-name></person-group><article-title>The WHO-5 well-being index</article-title>. <source>Psychother Psychosom</source>. <year>2015</year>;<volume>84</volume>(<issue>3</issue>):<fpage>167</fpage>-<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000376585</pub-id>.<pub-id pub-id-type="pmid">25831962</pub-id></mixed-citation></ref><ref id="pkae031-B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Olsen</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Jensen</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Noerholm</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Martiny</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bech</surname><given-names>P.</given-names></string-name></person-group><article-title>The internal and external validity of the major depression inventory in measuring severity of depressive states</article-title>. <source>Psychol Med</source><year>2003</year>;<volume>33</volume>(<issue>2</issue>):<fpage>351</fpage>-<lpage>356</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291702006724</pub-id>.<pub-id pub-id-type="pmid">12622314</pub-id></mixed-citation></ref><ref id="pkae031-B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zerssen</surname><given-names>D.</given-names></string-name></person-group><article-title>&#8220;Typus melancholicus&#8221; from a psychometric viewpoint (part 1)</article-title>. <source>Z Klin Psychol Psychother</source>. <year>1976</year>;<volume>24</volume>(<issue>3</issue>):<fpage>200</fpage>-<lpage>220</lpage>.<pub-id pub-id-type="pmid">1016469</pub-id></mixed-citation></ref><ref id="pkae031-B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Manassis</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mendlowitz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dupuis</surname><given-names>A</given-names></string-name></person-group>, <etal>et al</etal><article-title>Mood assessment via animated characters: an instrument to access and evaluate emotions in young children</article-title>. <source>OJPsych</source>. <year>2013</year>;<volume>03</volume>(<issue>01</issue>):<fpage>149</fpage>-<lpage>157</lpage>. doi:<pub-id pub-id-type="doi">10.4236/ojpsych.2013.31A010</pub-id>.</mixed-citation></ref><ref id="pkae031-B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Amorim</surname><given-names>P.</given-names></string-name></person-group><article-title>Mini international neuropsychiatric interview (MINI): valida&#231;&#227;o de entrevista breve para diagn&#243;stico de transtornos mentais</article-title>. <source>Rev Bras Psiquiatr</source>. <year>2000</year>;<volume>22</volume>(<issue>3</issue>):<fpage>106</fpage>-<lpage>115</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1516-44462000000300003</pub-id>.</mixed-citation></ref><ref id="pkae031-B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Spitzer</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Kroenke</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Lowe</surname><given-names>B.</given-names></string-name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title>. <source>Arch.Intern.Med</source>. <year>2006</year>;<volume>166</volume>(<issue>10</issue>):<fpage>1092</fpage>-<lpage>1097</lpage>. doi:166/10/1092 [pii].<pub-id pub-id-type="pmid">16717171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.166.10.1092</pub-id></mixed-citation></ref><ref id="pkae031-B48"><label>48</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Parisi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Salerno</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Maltese</surname><given-names>A</given-names></string-name></person-group>, <etal>et al</etal><italic toggle="yes">State-Trait Anxiety Inventory for Adults</italic>. American Psychological Association; <year>2017</year>. doi:<pub-id pub-id-type="doi">10.1037/t06496-000</pub-id>.</mixed-citation></ref><ref id="pkae031-B49"><label>49</label><mixed-citation publication-type="journal">Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. <italic toggle="yes">J Consult Clin Psychol [Internet]</italic>. 1988;<volume>56</volume>(<issue>6</issue>):<fpage>893</fpage>-<lpage>897</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1037//0022-006x.56.6.893</pub-id><pub-id pub-id-type="pmid">3204199</pub-id></mixed-citation></ref><ref id="pkae031-B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zung</surname><given-names>W.</given-names></string-name></person-group><article-title>A rating instrument for anxiety disorders</article-title>. <source>Psychosomatics</source>. <year>1971</year>;<volume>12</volume>(<issue>6</issue>):<fpage>371</fpage>-<lpage>379</lpage>.<pub-id pub-id-type="pmid">5172928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0033-3182(71)71479-0</pub-id></mixed-citation></ref><ref id="pkae031-B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>King</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>IM.</given-names></string-name></person-group><article-title>A manifest anxiety scale from the MMPI-168</article-title>. <source>J Clin Psychol</source><year>1986</year>;<volume>42</volume>(<issue>5</issue>):<fpage>748</fpage>-<lpage>751</lpage>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://f" ext-link-type="uri">f</ext-link>. doi:<pub-id pub-id-type="doi">10.1002/1097-4679(198609)42:53.0.CO;2-J</pub-id>.<pub-id pub-id-type="pmid">3760206</pub-id></mixed-citation></ref><ref id="pkae031-B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Donovan</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Grassi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>McGinty</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Jacobsen</surname><given-names>PB.</given-names></string-name></person-group><article-title>Validation of the distress thermometer worldwide: state of the science</article-title>. <source>Psychooncology</source>. <year>2014</year>;<volume>23</volume>(<issue>3</issue>):<fpage>241</fpage>-<lpage>250</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.3430</pub-id>.<pub-id pub-id-type="pmid">25160838</pub-id></mixed-citation></ref><ref id="pkae031-B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Abdel-Khalek</surname><given-names>AM.</given-names></string-name></person-group><article-title>The arabic scale of death anxiety (asda): its development, validation, and results in three arab countries</article-title>. <source>Death Stud</source><year>2004</year>;<volume>28</volume>(<issue>5</issue>):<fpage>435</fpage>-<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07481180490437572</pub-id>.<pub-id pub-id-type="pmid">15152649</pub-id></mixed-citation></ref><ref id="pkae031-B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Recklitis</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname><given-names>P.</given-names></string-name></person-group><article-title>Screening childhood cancer survivors with the brief symptom inventory-18: Classification agreement with the symptom checklist-90-revised</article-title>. <source>Psychooncology</source><year>2007</year>;<volume>16</volume>(<issue>5</issue>):<fpage>429</fpage>-<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.1069</pub-id>.<pub-id pub-id-type="pmid">16929465</pub-id></mixed-citation></ref><ref id="pkae031-B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hystad</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Johnsen</surname><given-names>BH.</given-names></string-name></person-group><article-title>The dimensionality of the 12-item general health questionnaire (GHQ-12): comparisons of factor structures and invariance across samples and time</article-title>. <source>Front Psychol</source><year>2020</year>;<volume>11</volume>:<fpage>1300</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2020.01300</pub-id>.<pub-id pub-id-type="pmid">32595570</pub-id><pub-id pub-id-type="pmcid">PMC7300277</pub-id></mixed-citation></ref><ref id="pkae031-B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Penninkilampi-Kerola</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Miettunen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ebeling</surname><given-names>H.</given-names></string-name></person-group><article-title>A comparative assessment of the factor structures and psychometric properties of the GHQ-12 and the GHQ-20 based on data from a finnish population-based sample</article-title>. <source>Scand J Psychol</source><year>2006</year>;<volume>47</volume>(<issue>5</issue>):<fpage>431</fpage>-<lpage>440</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1467-9450.2006.00551.x</pub-id>.<pub-id pub-id-type="pmid">16987212</pub-id></mixed-citation></ref><ref id="pkae031-B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huppert</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Walters</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>NE</given-names></string-name>, <string-name name-style="western"><surname>Elliott</surname><given-names>BJ.</given-names></string-name></person-group><article-title>The factor structure of the general health questionnaire (GHQ-30). a reliability study on 6317 community residents</article-title>. <source>Br J Psychiatry</source><year>1989</year>;<volume>155</volume>(<issue>2</issue>):<fpage>178</fpage>-<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1192/bjp.155.2.178</pub-id>.<pub-id pub-id-type="pmid">2633776</pub-id></mixed-citation></ref><ref id="pkae031-B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koch</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gr&#228;fenstein</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Karnosky</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Schulz</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Koller</surname><given-names>M.</given-names></string-name></person-group><article-title>Screeningverfahren in der psychoonkologie, testinstumente zur identifikation betreuungsbed&#252;rftiger krebspatienten</article-title>. <source>Cancer Manag Res</source>. <year>2021</year>;<volume>13</volume>:<fpage>6191</fpage>-<lpage>6197</lpage>.<pub-id pub-id-type="pmid">34393512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CMAR.S314310</pub-id><pub-id pub-id-type="pmcid">PMC8357622</pub-id></mixed-citation></ref><ref id="pkae031-B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buysse</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Reynolds</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Monk</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Berman</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Kupfer</surname><given-names>DJ.</given-names></string-name></person-group><article-title>The pittsburgh sleep quality index: a new instrument for psychiatric practice and research</article-title>. <source>Psychiatry Res</source>. <year>1989</year>;<volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>-<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0165-1781(89)90047-4</pub-id> [pii].<pub-id pub-id-type="pmid">2748771</pub-id></mixed-citation></ref><ref id="pkae031-B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lang</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Wilkins</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Roy-Byrne</surname><given-names>PP</given-names></string-name></person-group>, <etal>et al</etal><article-title>Abbreviated PTSD checklist (PCL) as a guide to clinical response</article-title>. <source>Gen Hosp Psychiatry</source><year>2012</year>;<volume>34</volume>(<issue>4</issue>):<fpage>332</fpage>-<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2012.02.003</pub-id>.<pub-id pub-id-type="pmid">22460001</pub-id><pub-id pub-id-type="pmcid">PMC3383936</pub-id></mixed-citation></ref><ref id="pkae031-B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Foa</surname><given-names>EB</given-names></string-name>, <string-name name-style="western"><surname>Cashman</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jaycox</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Perry</surname><given-names>K.</given-names></string-name></person-group><article-title>The validation of a self-report measure of posttraumatic stress disorder</article-title>. <source>Psychological Assessment</source>. <year>1997</year>;<volume>9</volume>(<issue>4</issue>):<fpage>445</fpage>-<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.1037/1040-3590.9.4.445</pub-id>.</mixed-citation></ref><ref id="pkae031-B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Creamer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bell</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Failla</surname><given-names>S.</given-names></string-name></person-group><article-title>Psychometric properties of the impact of event Scale&#8212;Revised</article-title>. <source>Behav Res Ther</source><year>2003</year>;<volume>41</volume>(<issue>12</issue>):<fpage>1489</fpage>-<lpage>1496</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.brat.2003.07.010</pub-id>.<pub-id pub-id-type="pmid">14705607</pub-id></mixed-citation></ref><ref id="pkae031-B63"><label>63</label><mixed-citation publication-type="book"><collab>American Psychiatric Association.</collab><source>Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR</source>. <edition>4th ed</edition>., text revision ed. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>; <year>2000</year>.</mixed-citation></ref><ref id="pkae031-B64"><label>64</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <italic toggle="yes">International Classification of Diseases - 9th Version</italic>. Vol. <volume>2</volume>. <year>2012</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/standards/classifications/classification-of-diseases" ext-link-type="uri">https://www.who.int/standards/classifications/classification-of-diseases</ext-link>. Accessed August 30, 2023.</mixed-citation></ref><ref id="pkae031-B65"><label>65</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>The ICD-10 Classification of Mental and Behavioural Disorders</source>. Reprint ed. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>; <year>1993</year>.</mixed-citation></ref><ref id="pkae031-B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Endicott</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Spitzer</surname><given-names>RL.</given-names></string-name></person-group><article-title>A diagnostic interview: The schedule for affective disorders and schizophrenia</article-title>. <source>Arch Gen Psychiatry</source><year>1978</year>;<volume>35</volume>(<issue>7</issue>):<fpage>837</fpage>-<lpage>844</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.1978.01770310043002</pub-id>.<pub-id pub-id-type="pmid">678037</pub-id></mixed-citation></ref><ref id="pkae031-B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sheehan</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Lecrubier</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Sheehan</surname><given-names>KH.</given-names></string-name></person-group><article-title>The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>J Clin Psychiatry</source>. <year>1998</year>;<volume>59(suppl 20)</volume>:<fpage>34</fpage>-<lpage>57</lpage>.<pub-id pub-id-type="pmid">9881538</pub-id></mixed-citation></ref><ref id="pkae031-B68"><label>68</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <italic toggle="yes">International Classification of Diseases, Eleventh Revision (ICD-11).</italic><year>2021</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/standards/classifications/classification-of-diseases" ext-link-type="uri">https://www.who.int/standards/classifications/classification-of-diseases</ext-link>. Accessed August 30, 2023.</mixed-citation></ref><ref id="pkae031-B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Waraich</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Goldner</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Somers</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>L.</given-names></string-name></person-group><article-title>Prevalence and incidence studies of mood disorders: a systematic review of the literature</article-title>. <source>Can J Psychiatry</source><year>2004</year>;<volume>49</volume>(<issue>2</issue>):<fpage>124</fpage>-<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1177/070674370404900208</pub-id>.<pub-id pub-id-type="pmid">15065747</pub-id></mixed-citation></ref><ref id="pkae031-B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Flensborg-Madsen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bay von Scholten</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Flachs</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Mortensen</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Prescott</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Tolstrup</surname><given-names>JS.</given-names></string-name></person-group><article-title>Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study</article-title>. <source>J Psychiatr Res</source><year>2011</year>;<volume>45</volume>(<issue>2</issue>):<fpage>143</fpage>-<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2010.06.006</pub-id>.<pub-id pub-id-type="pmid">20630542</pub-id></mixed-citation></ref><ref id="pkae031-B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McHugh</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>RD.</given-names></string-name></person-group><article-title>Alcohol use disorder and depressive disorders</article-title>. <source>Alcohol Res</source><year>2019</year>;<volume>40</volume>(<issue>1</issue>):<fpage>3</fpage>-<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.35946/arcr.v40.1.01</pub-id>.<pub-id pub-id-type="pmcid">PMC6799954</pub-id><pub-id pub-id-type="pmid">31649834</pub-id></mixed-citation></ref><ref id="pkae031-B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Remes</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Mendes</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Templeton</surname><given-names>P.</given-names></string-name></person-group><article-title>Biological, psychological, and social determinants of depression: a review of recent literature</article-title>. <source>Brain Sci</source><year>2021</year>;<volume>11</volume>(<issue>12</issue>):<fpage>1633</fpage>. doi:<pub-id pub-id-type="doi">10.3390/brainsci11121633</pub-id>.<pub-id pub-id-type="pmid">34942936</pub-id><pub-id pub-id-type="pmcid">PMC8699555</pub-id></mixed-citation></ref><ref id="pkae031-B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shadrina</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bondarenko</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Slominsky</surname><given-names>PA.</given-names></string-name></person-group><article-title>Genetics factors in major depression disease</article-title>. <source>Front Psychiatry</source><year>2018</year>;<volume>9</volume>:<fpage>334</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00334</pub-id>.<pub-id pub-id-type="pmid">30083112</pub-id><pub-id pub-id-type="pmcid">PMC6065213</pub-id></mixed-citation></ref><ref id="pkae031-B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kasi</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Naqvi</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Afghan</surname><given-names>AK</given-names></string-name></person-group>, <etal>et al</etal><article-title>Coping styles in patients with anxiety and depression</article-title>. <source>ISRN Psychiatry</source><year>2012</year>;<volume>2012</volume>:<fpage>128672</fpage>-<lpage>128677</lpage>. doi:<pub-id pub-id-type="doi">10.5402/2012/128672</pub-id>.<pub-id pub-id-type="pmid">23738194</pub-id><pub-id pub-id-type="pmcid">PMC3658553</pub-id></mixed-citation></ref><ref id="pkae031-B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shapero</surname><given-names>BG</given-names></string-name>, <string-name name-style="western"><surname>Black</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>RT</given-names></string-name></person-group>, <etal>et al</etal><article-title>Stressful life events and depression symptoms: the effect of childhood emotional abuse on stress reactivity</article-title>. <source>J Clin Psychol</source><year>2014</year>;<volume>70</volume>(<issue>3</issue>):<fpage>209</fpage>-<lpage>223</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jclp.22011</pub-id>.<pub-id pub-id-type="pmid">23800893</pub-id><pub-id pub-id-type="pmcid">PMC3884028</pub-id></mixed-citation></ref><ref id="pkae031-B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mann</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lloyd-Evans</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>S.</given-names></string-name></person-group><article-title>Associations between loneliness and perceived social support and outcomes of mental health problems: a systematic review</article-title>. <source>BMC Psychiatry</source><year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>156</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12888-018-1736-5</pub-id>.<pub-id pub-id-type="pmid">29843662</pub-id><pub-id pub-id-type="pmcid">PMC5975705</pub-id></mixed-citation></ref><ref id="pkae031-B77"><label>77</label><mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. <source>Diagnostic and Statistical Manual of Mental Disorders</source>. <edition>5th ed</edition>. Virginia, USA: <publisher-name>American Psychiatric Association</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="pkae031-B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Park</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Hwang</surname><given-names>Y</given-names></string-name></person-group>, <etal>et al</etal><article-title>Risk factors for postoperative anxiety and depression after surgical treatment for lung cancer</article-title>. <source>Eur J Cardiothorac Surg</source><year>2016</year>;<volume>49</volume>(<issue>1</issue>):<fpage>e16</fpage>-<lpage>e21</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ejcts/ezv336</pub-id>.<pub-id pub-id-type="pmid">26410631</pub-id></mixed-citation></ref><ref id="pkae031-B79"><label>79</label><mixed-citation publication-type="other">Florez CI, Jurado A, Rodriguez-Borrego MA. N&#237;vel de ansiedade versus autocuidado no pr&#233;-operat&#243;rio e p&#243;s-operat&#243;rio do paciente laringectomizado total1 1 artigo extra&#237;do da tese de doutorado &#8220;nivel de ansiedad versus nivel de autocuidados en el paciente laringectomizado&#8221;, apresentada &#224; universidad de c&#243;rdoba, c&#243;rdoba, andaluc&#237;a, espanha. <year>2016</year>;24. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://search.proquest.com/docview/2719900092" ext-link-type="uri">https://search.proquest.com/docview/2719900092</ext-link>. doi:<pub-id pub-id-type="doi">10.1590/1518-8345.0743.2707</pub-id>.</mixed-citation></ref><ref id="pkae031-B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blanco-Pi&#241;ero</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Antequera-Jurado</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rodr&#237;guez-Franco</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ib&#225;&#241;ez-Guerra</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Herrero-Salado</surname><given-names>TF</given-names></string-name>, <string-name name-style="western"><surname>S&#225;nchez-G&#243;mez</surname><given-names>S.</given-names></string-name></person-group><article-title>Alteraciones emocionales y psicopatol&#243;gicas en pacientes oncol&#243;gicos laringectomizados</article-title>. <source>Acta Otorrinolaringol Esp</source>. <year>2015</year>;<volume>66</volume>(<issue>4</issue>):<fpage>210</fpage>-<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.otorri.2014.09.006</pub-id>.<pub-id pub-id-type="pmid">25465282</pub-id></mixed-citation></ref><ref id="pkae031-B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schimansky</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Beynon</surname><given-names>R</given-names></string-name></person-group>, <etal>et al</etal><article-title>Association between comorbidity and survival in head and neck cancer: results from head and neck 5000</article-title>. <source>Head Neck</source><year>2019</year>;<volume>41</volume>(<issue>4</issue>):<fpage>1053</fpage>-<lpage>1062</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hed.25543</pub-id>.<pub-id pub-id-type="pmid">30549147</pub-id><pub-id pub-id-type="pmcid">PMC6890487</pub-id></mixed-citation></ref><ref id="pkae031-B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Keam</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Machiels</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>HR</given-names></string-name></person-group>, <etal>et al</etal><article-title>Pan-asian adaptation of the EHNS&#8211;ESMO&#8211;ESTRO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck</article-title>. <source>ESMO Open</source><year>2021</year>;<volume>6</volume>(<issue>6</issue>):<fpage>100309</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.esmoop.2021.100309</pub-id>.<pub-id pub-id-type="pmid">34844180</pub-id><pub-id pub-id-type="pmcid">PMC8710460</pub-id></mixed-citation></ref><ref id="pkae031-B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Al-Salool</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Soror</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>NY</given-names></string-name></person-group>, <etal>et al</etal><article-title>Emotional distress in head-and-neck cancer patients scheduled for chemoradiation or radiotherapy alone</article-title>. <source>Anticancer Res</source><year>2023</year>;<volume>43</volume>(<issue>5</issue>):<fpage>2227</fpage>-<lpage>2233</lpage>. doi:<pub-id pub-id-type="doi">10.21873/anticanres.16386</pub-id>.<pub-id pub-id-type="pmid">37097669</pub-id></mixed-citation></ref><ref id="pkae031-B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pisu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>MY.</given-names></string-name></person-group><article-title>Financial toxicity: a common problem affecting patient care and health</article-title>. <source>Nat Rev Dis Primers</source><year>2022</year>;<volume>8</volume>(<issue>1</issue>):<fpage>7</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41572-022-00341-1</pub-id>.<pub-id pub-id-type="pmid">35145106</pub-id><pub-id pub-id-type="pmcid">PMC9731797</pub-id></mixed-citation></ref><ref id="pkae031-B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Witte</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mehlis</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Surmann</surname><given-names>B</given-names></string-name></person-group>, <etal>et al</etal><article-title>Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications</article-title>. <source>Ann Oncol</source><year>2019</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1061</fpage>-<lpage>1070</lpage>. doi:<pub-id pub-id-type="doi">10.1093/annonc/mdz140</pub-id>.<pub-id pub-id-type="pmid">31046080</pub-id><pub-id pub-id-type="pmcid">PMC6637374</pub-id></mixed-citation></ref><ref id="pkae031-B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shuman</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Duffy</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Ronis</surname><given-names>DL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Predictors of poor sleep quality among head and neck cancer patients</article-title>. <source>Laryngoscope</source><year>2010</year>;<volume>120</volume>(<issue>6</issue>):<fpage>1166</fpage>-<lpage>1172</lpage>. doi:<pub-id pub-id-type="doi">10.1002/lary.20924</pub-id>.<pub-id pub-id-type="pmid">20513034</pub-id><pub-id pub-id-type="pmcid">PMC3721672</pub-id></mixed-citation></ref><ref id="pkae031-B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McMillan</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Tofthagen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Morgan</surname><given-names>MA.</given-names></string-name></person-group><article-title>Relationships among pain, sleep disturbances, and depressive symptoms in outpatients from a comprehensive cancer center</article-title>. <source>Oncol Nurs Forum</source><year>2008</year>;<volume>35</volume>(<issue>4</issue>):<fpage>603</fpage>-<lpage>611</lpage>. doi:<pub-id pub-id-type="doi">10.1188/08.ONF.603-611</pub-id>.<pub-id pub-id-type="pmid">18591165</pub-id></mixed-citation></ref><ref id="pkae031-B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jellema</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Slotman</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Doornaert</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Leemans</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Langendijk</surname><given-names>JA.</given-names></string-name></person-group><article-title>Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer</article-title>. <source>Int J Radiat Oncol Biol Phys</source><year>2007</year>;<volume>69</volume>(<issue>3</issue>):<fpage>751</fpage>-<lpage>760</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2007.04.021</pub-id>.<pub-id pub-id-type="pmid">17560735</pub-id></mixed-citation></ref><ref id="pkae031-B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Friedman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Landsberg</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Pryor</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Syed</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ibrahim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Caldarelli</surname><given-names>DD.</given-names></string-name></person-group><article-title>The occurrence of sleep-disordered breathing among patients with head and neck cancer</article-title>. <source>Laryngoscope</source><year>2001</year>;<volume>111</volume>(<issue>11 Pt 1</issue>):<fpage>1917</fpage>-<lpage>1919</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005537-200111000-00008</pub-id>.<pub-id pub-id-type="pmid">11801969</pub-id></mixed-citation></ref><ref id="pkae031-B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kyle</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Morgan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Espie</surname><given-names>CA.</given-names></string-name></person-group><article-title>Insomnia and health-related quality of life</article-title>. <source>Sleep Med Rev</source><year>2010</year>;<volume>14</volume>(<issue>1</issue>):<fpage>69</fpage>-<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2009.07.004</pub-id>.<pub-id pub-id-type="pmid">19962922</pub-id></mixed-citation></ref><ref id="pkae031-B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chellappa</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Aeschbach</surname><given-names>D.</given-names></string-name></person-group><article-title>Sleep and anxiety: from mechanisms to interventions</article-title>. <source>Sleep Med Rev</source><year>2022</year>;<volume>61</volume>:<fpage>101583</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2021.101583</pub-id>.<pub-id pub-id-type="pmid">34979437</pub-id></mixed-citation></ref><ref id="pkae031-B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tsuno</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Besset</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ritchie</surname><given-names>K.</given-names></string-name></person-group><article-title>Sleep and depression</article-title>. <source>J Clin Psychiatry</source>. <year>2005</year>;<volume>66</volume>(<issue>10</issue>):<fpage>1254</fpage>-<lpage>1269</lpage>. doi:<pub-id pub-id-type="doi">10.4088/JCP.v66n1008</pub-id>.<pub-id pub-id-type="pmid">16259539</pub-id></mixed-citation></ref><ref id="pkae031-B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>S.</given-names></string-name></person-group><article-title>Alcohol consumption and incidence of sleep disorder: a systematic review and meta-analysis of cohort studies</article-title>. <source>Drug Alcohol Depend</source><year>2020</year>;<volume>217</volume>:<fpage>108259</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2020.108259</pub-id>.<pub-id pub-id-type="pmid">32927195</pub-id></mixed-citation></ref><ref id="pkae031-B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>De Berardis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Martinotti</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Di Giannantonio</surname><given-names>M.</given-names></string-name></person-group><article-title>Editorial: Understanding the complex phenomenon of suicide: from research to clinical practice</article-title>. <source>Front Psychiatry</source><year>2018</year>;<volume>9</volume>:<fpage>61</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00061</pub-id>.<pub-id pub-id-type="pmid">29545757</pub-id><pub-id pub-id-type="pmcid">PMC5839093</pub-id></mixed-citation></ref><ref id="pkae031-B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dent</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Szymanski</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Kelley</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Katz</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>McCarthy</surname><given-names>JF.</given-names></string-name></person-group><article-title>Suicide risk following a new cancer diagnosis among veterans in Veterans Health Administration care</article-title>. <source>Cancer Med</source><year>2023</year>;<volume>12</volume>(<issue>3</issue>):<fpage>3520</fpage>-<lpage>3531</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cam4.5146</pub-id>.<pub-id pub-id-type="pmid">36029038</pub-id><pub-id pub-id-type="pmcid">PMC9939100</pub-id></mixed-citation></ref><ref id="pkae031-B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Choi</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>E.</given-names></string-name></person-group><article-title>Suicide risk after cancer diagnosis among older adults: a nationwide retrospective cohort study</article-title>. <source>J Geriatr Oncol</source><year>2020</year>;<volume>11</volume>(<issue>5</issue>):<fpage>814</fpage>-<lpage>819</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jgo.2019.11.006</pub-id>.<pub-id pub-id-type="pmid">31787493</pub-id></mixed-citation></ref><ref id="pkae031-B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kam</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Salib</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gorgy</surname><given-names>G</given-names></string-name></person-group>, <etal>et al</etal><article-title>Incidence of suicide in patients with head and neck cancer</article-title>. <source>JAMA Otolaryngol Head Neck Surg</source>. <year>2015</year>;<volume>141</volume>(<issue>12</issue>):<fpage>1075</fpage>-<lpage>1078</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaoto.2015.2480</pub-id>.<pub-id pub-id-type="pmid">26562764</pub-id></mixed-citation></ref><ref id="pkae031-B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fried</surname><given-names>EI</given-names></string-name>, <string-name name-style="western"><surname>Nesse</surname><given-names>RM.</given-names></string-name></person-group><article-title>Depression sum-scores don&#8217;t add up: why analyzing specific depression symptoms is essential</article-title>. <source>BMC Med</source>. <year>2015</year>;<volume>13</volume>(<issue>1</issue>):<fpage>72</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12916-015-0325-4</pub-id>.<pub-id pub-id-type="pmid">25879936</pub-id><pub-id pub-id-type="pmcid">PMC4386095</pub-id></mixed-citation></ref><ref id="pkae031-B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Arias-de la Torre</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Vilagut</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Serrano-Blanco</surname><given-names>A</given-names></string-name></person-group>, <etal>et al</etal><article-title>Accuracy of self-reported items for the screening of depression in the general population</article-title>. <source>IJERPH</source>. <year>2020</year>;<volume>17</volume>(<issue>21</issue>):<fpage>7955</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph17217955</pub-id>.<pub-id pub-id-type="pmid">33138196</pub-id><pub-id pub-id-type="pmcid">PMC7662518</pub-id></mixed-citation></ref><ref id="pkae031-B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wadsworth</surname><given-names>LP</given-names></string-name>, <string-name name-style="western"><surname>Wessman</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Bj&#246;rnsson</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Jonsdottir</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kristinsson</surname><given-names>SY.</given-names></string-name></person-group><article-title>The half-painted picture: reviewing the mental health impacts of cancer screening</article-title>. <source>Medicine (Baltimore)</source>. <year>2022</year>;<volume>101</volume>(<issue>38</issue>):<fpage>e30479</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000030479</pub-id>.<pub-id pub-id-type="pmid">36197248</pub-id><pub-id pub-id-type="pmcid">PMC9509034</pub-id></mixed-citation></ref><ref id="pkae031-B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vodermaier</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Linden</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Siu</surname><given-names>C.</given-names></string-name></person-group><article-title>Screening for emotional distress in cancer patients: a systematic review of assessment instruments</article-title>. <source>J Natl Cancer Inst</source><year>2009</year>;<volume>101</volume>(<issue>21</issue>):<fpage>1464</fpage>-<lpage>1488</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jnci/djp336</pub-id>.<pub-id pub-id-type="pmid">19826136</pub-id><pub-id pub-id-type="pmcid">PMC3298956</pub-id></mixed-citation></ref><ref id="pkae031-B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rosendahl</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gawlytta</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ressel</surname><given-names>E</given-names></string-name></person-group>, <etal>et al</etal><article-title>Efficacy of group therapy to reduce mental distress in women with non&#8208;metastatic breast cancer: a systematic review and meta&#8208;analysis of randomized controlled trials</article-title>. <source>Psychooncology</source><year>2023</year>;<volume>32</volume>(<issue>3</issue>):<fpage>331</fpage>-<lpage>341</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.6082</pub-id>.<pub-id pub-id-type="pmid">36588187</pub-id></mixed-citation></ref><ref id="pkae031-B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Breitbart</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Rosenfeld</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Gibson</surname><given-names>C</given-names></string-name></person-group>, <etal>et al</etal><article-title>Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial</article-title>. <source>Psychooncology</source><year>2010</year>;<volume>19</volume>(<issue>1</issue>):<fpage>21</fpage>-<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pon.1556</pub-id>.<pub-id pub-id-type="pmid">19274623</pub-id><pub-id pub-id-type="pmcid">PMC3648880</pub-id></mixed-citation></ref><ref id="pkae031-B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Greenland</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Morgenstern</surname><given-names>H.</given-names></string-name></person-group><article-title>Ecological bias, confounding, and effect modification</article-title>. <source>Int J Epidemiol</source><year>1989</year>;<volume>18</volume>(<issue>1</issue>):<fpage>269</fpage>-<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/18.1.269</pub-id>.<pub-id pub-id-type="pmid">2656561</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>